The cyanobacterial pigments scytonemin and nostodione A - Synthesis, photophysicochemical behavior and biological studies by Ekebergh, Andreas
i 
 
THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY 
 
 
 
 
 
 
 
 
 
The cyanobacterial pigments scytonemin and nostodione A 
 
Synthesis, photophysicochemical behavior  
and biological studies 
 
 
 
ANDREAS EKEBERGH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Department of Chemical and Biological Engineering 
 
CHALMERS UNIVERSITY OF TECHNOLOGY 
 
Gothenburg, Sweden 2014 
 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The cyanobacterial pigments scytonemin and nostodione A 
Synthesis, photophysicochemical behavior and biological studies 
 
Andreas Ekebergh 
ISBN 978-91-7597-125-4 
 
© ANDREAS EKEBERGH, 2014. 
 
Doktorsavhandlingar vid Chalmers tekniska högskola 
Ny serie nr 3806 
ISSN 0346-718X 
 
Department of Chemical and Biological Engineering 
Chalmers University of Technology 
SE-412 96 Gothenburg 
Sweden 
Telephone + 46 (0)31-772 1000 
 
Cover: Top: Response surface map displaying the ligand effect on a cascade Heck-Suzuki 
reaction. Middle: Cells treated with monomer 70e together with its structure. Bottom: 
Absorption spectra for the photo-decay of scytonemin together with its structure. 
 
 
 
Printed by Chalmers Reproservice 
Gothenburg, Sweden 2014  
iii 
 
The cyanobacterial pigments scytonemin and nostodione A 
 
Synthesis, photophysicochemical behavior  
and biological studies 
 
ANDREAS EKEBERGH 
 
Department of Chemical and Biological Engineering 
Chalmers University of Technology 
 
 
ABSTRACT 
 
The natural UV-screener scytonemin is found in a plethora of cyanobacterial species. Its UV-
protective ability allows the bacteria to thrive in inhospitable locations exposed to intense 
solar radiation. Scytonemin has a dimeric structure consisting of two 1-1' linked 3-(4-
hydroxybenzylidene)cyclopenta[b]indole-2-one moieties. The cyanobacterial pigment 
nostodione A consists of the same skeleton, but is not symmetrically appended at C-1. Instead 
it appears as a 1,2-dione. Both natural products have displayed attractive bioactivity, e.g. 
inhibition of cancer cell mitosis and in vitro reduction of kinase activity.  
 In this study, flexible synthetic strategies leading to the 3-alkenyl-
cyclopenta[b]indole-2-one skeleton have been investigated, with focus on different ring-
closing methods for the annulation of indoles. In particular, statistical experimental design has 
been utilized to successfully optimize a cascade Heck-Suzuki reaction. Here, the 
cyclopentanone is fused onto the indole with the concurrent assembly of the exocyclic alkenyl 
moiety. The route has been employed to construct a number of 3-alkenyl-cyclopenta[b]indole-
2-one containing compounds with various substituents around the exocyclic double bond. 
Both the total synthesis of scytonemin and of nostodione A could be completed from suitable 
3-alkenyl-cyclopenta[b]indole-2-one fragments, the former via an oxidative enolate coupling 
of two monomers and the latter via a selective oxidation.  
 A number of relevant derivatives were synthesized via the developed synthetic route 
and used to investigate the photophysicochemical properties of scytonemin. Scytonemin 
demonstrated a low photo-stability in organic solvents, contradictory to its reported behavior 
in vivo. In cyanobacterial colonies, scytonemin is located in the extra cellular polysaccharide 
matrix, which likely has a stabilizing effect on scytonemin. 
 Lastly, elaboration of the 3-alkenyl-cyclopenta[b]indole-2-one skeleton into kinase 
inhibitors relevant for combating melanoma was pursued. The kinase inhibiting properties of 
17 substances, including scytonemin and nostodione A, were studied. Activity against the 
clinically proven melanoma target BRAF V600E was found and the most promising 
compound also displayed favorable properties in cell studies.  
 
 
Keywords: Scytonemin, nostodione A, UV-screeners, photo-stability, design of experiments, 
palladium catalysis, cascade reactions, gold catalysis, ligand effect, kinase inhibitor. 
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1 Introduction and background 
1.1 Introduction to organic chemistry and synthesis of natural products 
In the beginning of the nineteenth century, it was believed that organic compounds 
(substances containing carbons and hydrogens) could not be synthesized, but had to be 
obtained directly from living organisms.1 Looking at the vast field of organic chemistry, 
which today consists of more methods for creating and manipulating organic molecules than 
any one person can comprehend, such a belief seem distant. The significance of organic 
chemistry, and consequently the high research interest, is easily understood considering how 
it contributes both to fundamentally understanding our surrounding as well as concretely 
giving us means to create new materials and pharmaceuticals. 
Organic chemistry can be split into several subfields, one being the total synthesis of natural 
products. Natural products, also known as secondary metabolites, are small organic molecules 
found in living organisms. They are distinguished from compounds that are essential to all 
life, primary metabolites, which consequently are found in all life forms. Instead, different 
natural products are found in different types of organisms, i.e. a particular natural product is 
found exclusively in a particular organism. For a long time, natural products were thought to 
have no explicit role in the organism in which it was produced. Today, numerous natural 
products have been established to assist with important functions, such as attracting 
pollinators (for plants) and preventing infections, ultimately enhancing the organisms 
survivability.2-4 
The synthesis of natural products has attracted the attention of many an organic chemists. One 
rationale to the attention lies in the chemical complexity found in numerous natural products. 
The synthesis of such targets have led to many innovative solutions of synthetic problems and 
brought novel knowledge to the field. Further, to quote K.C. Nicolaou and S.A. Snyder, "they 
also provide one of the best forums in which to identify synthetic inadequacies worthy of 
further methodological development".5 Another rationale relates to the biological activity 
frequently encountered among natural products.6 Synthesizing natural products, and 
analogues of them, can be used as a platform for developing new bioactive compounds, i.e. 
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pharmaceuticals. Today, the majority of total synthesis reported concerns natural products 
with inherent bioactivity.  
1.2 Scytonemin and nostodione A 
1.2.1 Occurrence, isolation and structure 
Scytonemin (1) and nostodione A (2) are pigments found exclusively in cyanobacteria. 
Scytonemin was reported already in 1849 by Nägeli,7 and was subsequently mentioned in 
several papers during the 20:th century. The compound was however not isolated until 1991 
when Garcia-Pichel and Castenholz did a first in depth study of it.8 They identified it in over 
30 species of cyanobacteria, where it mainly occurred in the extracellular matrix, which 
consists mostly of high molecular weight polysaccharides, but also different proteins.9, 10 
Scytonemin was early on demonstrated to strongly absorb UV-light.8 The absorbance is 
strongest in the UVA-(315-400nm) and UVC-regions (100-280nm), while less pronounced in 
the UVB-region (280-315nm). Scytonemin was also demonstrated to exist in two different 
forms, a predominant oxidized green/brown form and a reduced red form. The two could be 
interconverted by reducing/oxidizing agents. The unique dimeric structure of scytonemin 
(Figure 1) was determined in 1993 along with its reduced form (3).11 The structure consists of 
a cyclopenta[b]indole-2-one system, appended with a phenol substituted alkenyl group in the 
three position. Scytonemin has since then been explored in many different types of studies, 
vide infra. 
Nostodione A (2), having a close structural resemblance to scytonemin, has received far less 
attention. It was first isolated from cyanobacteria in 1994 by Kobayashi who characterized it 
as a pair of rapidly interconverting stereo-isomers (Figure 1).12 This was however not the first 
report of nostodione A. Unknowingly, a semi-total synthesis of the natural product was 
performed in 1993 when ozonolysis of reduced scytonemin (3) yielded nostodione A during 
the scytonemin characterization campaign.11 Two additional reports on the isolation of 
nostodione A have since then been published.13, 14 Apart from scytonemin and nostodione A, 
single reports on the isolation of five additional closely related natural products have been 
accounted for (Figure 1).13, 15, 16  
1.2.2 Biological role 
In their study from 1991, Garcia-Pichel and Castenholz proposed that scytonemin (1) is a part 
of a UV-protective strategy adopted by cyanobacteria.8 The proposed function was validated 
by the same researchers only a year later when mats of cyanobacteria were grown in a light 
controlled environment. The experiment revealed that scytonemin synthesis was triggered by 
UV-light and that cyanobacteria containing scytonemin were more resilient toward UV-light 
than those without.17 Further, scytonemin has been proposed to have an ancient origin, being 
present as a cyanobacterial sun protective metabolite already during the Precambrian time 
period (~2 × 109 years ago).18  
Complementary to these studies, the connection between UV-light, cyanobacteria and 
scytonemin has been studied on several occasions.19 However, photo-protection is not the sole  
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Figure 1. Structures of cyanobacterial metabolites: Scytonemin (1), nostodione A (2), reduced 
scytonemin (3), scytonemin-imin (4), dimethoxyscytonemin (5), tetramethoxyscytonemin (6), 
prenostodione (7) and scytonine (8). 
role of scytonemin, but its function as an antioxidant has also been established. The 
combination of oxidative stress (reactive oxygen) and UV-light enhance the biosynthesis of 
scytonemin compared to UV-light alone.20 Further, isolated scytonemin has demonstrated 
radical scavenging properties in vitro by a conventional assay.21 
The role of nostodione A (2) has yet to be elucidated. It has been proposed as a biosynthetic 
precursor in the synthesis of scytonemin,22 which is a credible explanation considering that 
scytonemin is biosynthetically derived from a monomeric precursor (see chapter 1.2.3 below). 
Upon its extraction from cyanobacteria, prenostodione (7) was suggested to be a precursor to 
nostodione A, which also explains its name.13 However, nostodione A is likely constructed 
via the same pathway as scytonemin, which does not contain prenostodione as an 
intermediate, making the suggested role questionable. The cyanobacterial production of 
scytonemin-imin (4) has been reported to be dependent on intense UV-radiation. Further, its 
absorption is red-shifted compared to scytonemin and has therefore been proposed to shield 
chlorophyll from visible light during intense solar radiation.16 The same explanation could be 
adopted for dimethoxy- (5) and tetramethoxyscytonemin (6) as well, both having a red-shifted 
absorption. Finally, a degradation pathway from reduced scytonemin has been propositioned 
for scytonine (8).15 
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1.2.3 Biosynthesis 
Over the last 7 years, great progresses have been made to understand the biosynthesis of 
scytonemin (1). In 2007, Soule et al. presented a genomic study of the cyanobacteria Nostoc 
Punctiforme, revealing a cluster of 18 genes involved in the synthesis of scytonemin.23 
Several of the genes involved were determined to code for tryptophan and tyrosine synthesis, 
which are the two amino acid precursors of scytonemin. However, a number of genes were 
established to have no comparable function in any other organism and were therefore 
anticipated to be specific for the scytonemin biosynthesis. In 2008, two genes in the cluster 
were translated into proteins.24 These were demonstrated in vitro to first catalyze the 
formation of indole-3-pyruvic acid from tryptophan and then to couple it with p-
hydroxyphenylpyruvic acid, generating 11 (SCHEME 1). The function of a third gene was 
established one year later.25 Its corresponding protein catalyzed a ring closing reaction of 11, 
forming a monomeric form (12) of scytonemin. The functions of the remaining unknown 
genes are yet to be elucidated, but they should involve an oxidation of 12 and a subsequent 
coupling of two monomers into the dimeric structure of scytonemin.  
SCHEME 1. Initial biosynthetic steps toward scytonemin, catalyzed by the enzymes ScyB, ScyA and 
ScyC. 
 
Utilizing the biosynthetic breakthroughs, an attempt to produce scytonemin in E. Coli has 
recently been presented.26 The gene cluster associated with scytonemin was inserted into the 
bacteria, giving them the ability to produce an oxidized form of scytonemin monomer 12 
together with a number of byproducts, but not scytonemin itself. The results suggest either 
that additional genes are necessary for the complete synthesis or that the synthesis requires the 
specific cellular environment of the cyanobacteria. 
1.2.4 Artificial synthesis 
The cyclopenta[b]indole-2-one part of scytonemin (1) and nostodione A (2) has been 
synthesized via various methods.27-33 However, apart from our accounts on the total syntheses 
of scytonemin (2011) and nostodione A (2012),34, 35 only one synthesis has been reported of 
the cyclopenta[b]indole-2-one system with an exocyclic double bond in position three.36 In 
their report, McNulty and co-workers present an elegant route to nostodione A. The route is 
designed around an acidic phosphonate which is utilized on double occasions, first to ring-
close a 2,3-disubstituted indole and then in a Horner-Wadsworth-Emmons reaction to install 
the exocyclic double bond. The route was used to synthesize a number of derivatives which 
were assayed against the parasite Toxoplasma gondii. 
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1.2.5 Biological activity 
The bioactivity of scytonemin (1) has been evaluated in several studies. It was in 2002 
characterized as a possible antiproliferative pharmacophore, demonstrating the ability to 
inhibit several kinases involved in the cell cycle regulatory mechanism.37 In agreement with 
cell-cycle inhibition, tumor cells treated with scytonemin were shown to undergo apoptosis 
while non-proliferating cells treated with scytonemin remained intact. Since then, its 
antiproliferative effect on a number of cancer cell types has been established.38-41 Scytonemin 
has also been characterized as an anti-inflammatory agent, reducing induced ear edema and 
skin inflammation in mice.42, 43 A suggested mechanism involves inhibition of the NF-κB 
transcription factor, which activity is regulated by kinases.  
The ability of nostodione A (2) to inhibit cell-division of sea urchin eggs was established 
concurrent with its first isolation in 1994.12 The ability originated from a destructive 
interaction with the mitotic spindle during cell mitosis. Later, nostodione A was also found to 
inhibit proteasomes and the parasite Toxoplasma gondii.14, 36 
1.3 Sunscreens, skin cancer and allergy 
Exposure of the human body to solar UV-radiation has both beneficial and harmful effects. 
Production of vitamin D, necessary for several body functions, is well known to be dependent 
on UV-radiation.44, 45 Too much sun exposure has on the other hand been linked to the 
development of the three most common types of skin cancers; squamous cell cancer, basal 
cell cancer and melanoma. The two first skin cancer types are associated with chronic UV 
exposure, while melanoma has been related to intermittent and intense UV exposure, 
especially when exposed at a younger age. 46, 47 
The use of sunscreens have been reported to reduce the risk of squamous cell cancer, while its 
effect on basal cell cancer and melanoma is inconclusive.48 Although beneficial as UV-
protection, sunscreens have been associated with negative side-effects, such as photo-allergic 
contact dermatitis (PACD).49 PACD originates from sunscreens insufficiently stable toward 
UV-radiation. While the sunscreen in itself may be safe, the photo-degradation products 
formed can potentially be allergenic. For instance, it is well known that the commonly used 
sunscreen avobenzone (13) can cause allergy.50 The allergenic mechanism was investigated in 
the dissertation thesis of I. Karlsson, who established that avobenzone degrades into benzils 
(14) and arylglyoxals (15) upon UV-irradiation (SCHEME 2).51, 52 The former was shown to 
be cytotoxic while the latter was strongly allergenic. Thus, the allergenic mechanism of 
avobenzone is indeed that of photo-allergenic contact dermatitis. Consequently, photo-
stability is an important factor to account for in sunscreen design.  
SCHEME 2. Photo-degradation of avobenzone (13) into cytotoxic benzils (14) and allergenic 
arylglyoxals (15). 
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Nature is often used as an inspirational source to solve problems. The natural UV-screener 
scytonemin (1) has been proposed as a potential sunscreen on several occasions. It has a broad 
absorption in the UV-region and has also been reported to be photo-stable. With its ancient 
history,18 one could also argue that scytonemin is evolutionary favorable, thus having inherent 
traits which cannot be improved upon further by the evolutionary mechanism. This of course 
raises the question: Are those traits favorable for sunscreens in a general sense, or simply 
favorable for the cyanobacteria? 
1.4 Advanced melanoma 
Melanoma has continuously increased in occurrence over the last 30 years.53 Despite the 
negative trend in melanoma incidence, no significant change in mortality has been observed. 
The development is likely a result of increasingly better methods for early recognition of 
melanoma, which often results in successful surgical removal of the tumor. However, if not 
detected in time, melanoma will eventually spread to other parts of the body (advanced 
melanoma). Once spread, the prognostic outlook is poor with a median survival of about 6 to 
10 month, which cannot be improved upon with traditional chemotherapies.54, 55  
In 2002, Davies et al. found mutations in the gene coding for the kinase BRAF in over 60% of 
the tested melanoma, with a single mutation, BRAF V600E, found in 52% of the cases.56 
BRAF is part of the mitogen-activated protein kinase (MAPK) pathway, which regulates 
cellular events such as proliferation, cell cycle regulation and cell survival.57 External cellular 
stimuli activate the pathway, which in a cascade event ultimately lead to gene transcription. 
BRAF is in this sequence activated by the upstream kinase RAS and activates the downstream 
kinase MEK. However, the BRAF V600E mutant is inherently active, resulting in a 
constantly active MAPK pathway.58 Melanoma cancer cells have demonstrated a high 
dependency on the mutated pathway and selective inhibition of BRAF induces apoptosis.59 
The new therapeutically relevant information spawned an intense search for selective BRAF-
inhibitors with a good therapeutic profile. In 2011, a first inhibitor (vemurafenib) was 
approved for the treatment of BRAF V600E mutation-positive melanoma. In phase three 
clinic trials, the BRAF inhibitor displayed a reduction in the risk of death by 63% compared 
to chemotherapy.60, 61 However, the treatment is associated with a number of adverse side 
effects, such as squamous-cell carcinoma and photosensitivity. Another major problem is 
tumor adaptation resulting in replenished growth of the tumor after a few month of 
treatment.58 A number of adaptive mechanisms have been elucidated so far. A common 
denominator for several mechanisms is a BRAF dimerization process, in which BRAF form 
new active dimeric complexes together with other proteins, toward which the inhibitor is 
ineffective. A number of different strategies are emerging to overcome resistance, e.g. 
combination of different kinase inhibitors and periodical use of BRAF-inhibitors. Another 
strategy focus on developing inhibitors effective against the mutant BRAF-dimers. Some 
success in this area have been achieved with a second generation BRAF inhibitors.62 
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2 Objectives 
Three main objectives were pursued in this study:  
1) To develop a concise, flexible synthetic route to scytonemin, nostodione A and derivatives 
of them relevant for achieving objectives 2 and 3. Specifically, the route should offer the 
possibility of constructing derivatives with different substituents around the exocyclic double 
bond (Figure 2), which is considered to be important in the studies of the photophysical 
behavior (objective 2) as well as bioactivity (objective 3).  
2) To investigate and evaluate the photophysicochemical properties of scytonemin, ultimately 
to determine its viability as a sun screening compound.  
3) To explore the possibility of developing melanoma relevant kinase inhibitors based on the 
3-alkenyl-cyclopenta[b]indole-2-one skeleton of scytonemin and nostodione A.  
N
O
R1
N
O
R1 NH
O
R1
R2
O
R2
R2
16 17
1
2
3
1
2
3
 
Figure 2. Scytonemin scaffold 16 and nostodione A scaffold 17, which should be conceivable to 
construct with the synthetic route. Molecule numbering is displayed for the three first positions. 
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3 Theory and methodology 
Theory and methods central to this thesis are reviewed here. These include accounts for 
palladium- and gold-catalyzed cyclizations, Design of Experiments methodology, chemistry 
of excited states and ligand-kinase interactions. 
3.1 Palladium catalysis: The Suzuki and Heck reactions 
Numerous palladium catalyzed methods for creating carbon-carbon bonds have been 
developed over the last couple of decades.63 The palladium catalyzed reactions are usually 
characterized by mild reaction conditions and great selectivity toward the desired chemical 
outcome. Palladium catalysis recently gained attention when the Nobel prize was awarded to 
Akira Suzuki, Richard Heck and Ei-ichi Negishi for their work in the field.64 A short 
summary of Suzuki and Heck reaction theory is presented here. 
3.1.1 Suzuki reaction 
The palladium catalyzed reaction between an organoboron compound and an aryl or vinyl 
halide is known as the Suzuki reaction.63, 65 The organoboron species is most often a boronic 
acid or a boronic acid precursor which is hydrolyzed in situ. The reaction mechanism is 
usually described by three discrete steps. First, an oxidative addition of palladium(0) (18) to 
the organohalide (19) forms a 16-electron square planar trans-palladium(II)-complex (20). A 
subsequent transmetallation, where a carbon migrates from the boronic acid (22) to the 
palladium, generate a new square planar trans-complex (23). Finally, a cis/trans isomerization 
and reductive elimination form the new carbon-carbon bond in product 24 (SCHEME 3). 
Albeit the 16-electron square planar complex is usually invoked as an intermediate, both 14-
electron and 18-electron species are now being proposed as active species, vide infra. Typical 
reaction conditions involve a palladium precatalyst, ligands (most often of a phosphor-donor 
type), solvent and hydroxide ions or base/water.63  
The rate of oxidative addition depends strongly on the halide or pseudo halide in the substrate. 
The relative rate has been established as: PhI >> PhOTf >PhBr >> PhCl.66, 67 The rate further 
10 
 
SCHEME 3. Simplified mechanism of the Suzuki reaction. I: Oxidative addition, II: Transmetallation, 
III: Reductive elimination. L: Ligand, X : Halide or pseudo halide. Formed C-C bond in bold. 
 
depends on the electron density of the compound. For both para substituted PhI and PhOTf, 
Hammet free-energy relationship studies have demonstrated an increased rate for electron 
deficient compounds. A recent study of the oxidative addition found that the active 
palladium(0) species depends on the halide.68 While iodo-arenes react with a bi-ligated 
palladium(0) complex, the less reactive chloro-arenes proceed via mono-ligated palladium. 
The observation is further supported by calculations, where mono-ligated palladium has been 
put forward as more reactive and as such necessary for activation of unreactive chloro-carbon 
bonds.69 It was further demonstrated that ligand bulk affected the active species, but much 
less so than the halide. Bulky, electron rich ligands can on the other hand stabilize mono-
ligated complexes.70 Consequently, even though the bulk does not affect the oxidative 
addition transition state, the ability of bulky ligands to force the reaction into a mono-ligated 
pathway will increase the reaction rate.71 Further, the pure electronic properties of the ligand 
have been computationally demonstrated to affect the oxidative addition, with a positive 
correlation between ligand σ-donating capacity and rate.72 
The transmetallation is comparably difficult to investigate, and is therefore less studied than 
oxidative addition. Most efforts have been aimed toward elucidating the role of water. Two 
pathways have been suggested, the first involves formation of a boronate complex (25) prior 
to transmetallation, and the second involves a palladium hydroxide species (21) (SCHEME 
4).73 It is now generally accepted that the latter mechanism is correct, and that the oxophilic 
organoboron species will coordinate to the hydroxide (26) in the transmetallation step.74, 75 
Both electron deficient ligands (better π-acceptors) and substrates (the organohalide and 
organoboron species) have been proposed by computational studies to accelerate the 
transmetallation.72, 76 Ligands with good π-accepting abilities have been suggested to better 
accommodate the buildup of negative charge on the palladium during carbon migration and 
thereby reduce the transition state energy (see 27 in SCHEME 4). 
A prerequisite condition for reductive elimination is a cis-configuration (28) of the 
eliminating species (SCHEME 5). The 16-electron square planar palladium complex is 
however more stable in a trans-configuration, resulting in unfavorable conditions for 
reductive elimination.63 Instead, 14-electron mono-ligated T-shaped complexes (30) have 
been suggested in kinetic investigations as the active species.77, 78 Ligands stabilizing mono- 
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SCHEME 4. Two proposed pathways of the transmetallation. L : Ligand, X : Halide or pseudo halide. 
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ligated complexes can therefore possibly operate via this mechanism.70 18-electron penta-
coordinated anionic complexes (29) have also been invoked as active species in reductive 
elimination.79 In Suzuki couplings, hydroxyl ions have been suggested to coordinate to 
palladium prior to the reductive elimination, forming such a penta-coordinated complex.74 
The electronic properties of the ligand also affect the reductive elimination, with electron 
deficient ligands increasing the rate.80, 81 Electron donating ligands have been suggested to 
stabilize the electron deficient Pd(II)-complex and thereby increasing the transition energy 
barrier. An opposite dependence of the substrates have been proposed, thus electron rich 
substrates accelerate the reductive elimination.76 
The relative rate of the catalytic steps depends on many factors: electronic and steric 
properties of substrates and ligands, additives, solvents etc. When using aryl chlorides, it is 
typically the oxidative addition that is rate limiting. Aryl iodides on the other react fast in 
oxidative addition and the transmetallation have in a model system been determined as the 
rate determining step.74 Regarding ligands, both oxidative addition and reductive elimination 
have been suggested to benefit from mono-ligated palladium species, which are stabilized by 
large and electron rich ligands. Both transmetallation and reductive elimination benefit from 
electron poor ligands, while oxidative addition benefit from electron rich. Taken together, the 
choice of ligand depends on both steric and electronic properties and the optimal option varies 
with the substrate. 
SCHEME 5. Possible complexes active in the reductive elimination. 
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3.1.2 Heck annulations involving alkynes 
The Heck reaction82, 83 is usually described as a catalytic cycle made up by four discrete 
subreactions (SCHEME 6); an oxidative addition of palladium(0) to an aryl halide 19 (can 
also be a vinyl halide), a syn-carbopalladation of the palladium(II) species 20 to an alkene 31 
(can also be an alkyne), a β-hydride elimination of intermediate 32 to produce the organic 
product 33 and finally a reductive elimination of a hydrogen and a halide to regenerate the 
active palladium(0).  
SCHEME 6. Catalytic cycle of the Heck reaction. I: Oxidative addition, II: Carbopalladation, III: β-
hydride elimination, IV: Reductive elimination. L: Ligand, X: Halide or pseudohalide. Formed C-C 
bond in bold. 
 
An intramolecular, ring forming Heck reaction is obtained when the alkene/alkyne is tethered 
to the organohalide. Using alkynes without available β-hydrogens generate a special case in 
which the reaction cannot proceed past carbopalladation (SCHEME 7).84-92 Instead, in the 
presence of a transmetallation reagent 22, the "trapped" species 37 proceed to form a complex 
of type 38. The palladium species 38 can via reductive elimination form product 39 and 
regenerate the palladium(0)-complex. Two C-C bond forming events take place through the 
course of the reaction, first in the carbopalladation and then in the reductive elimination. 
When the transmetallation reagent is a organoboron, the reaction is known as a 
tandem/cascade Heck-Suzuki reaction. Intramolecular Heck reactions involving alkynes have 
been used exclusively in this project and the remainder of this chapter will discuss some 
theoretical aspects of it. Focus will be on carbopalladation as the other elemental steps have 
been previously discussed in chapter 3.1.1 above. 
Intramolecular carbopalladations involving alkynes proceed regiospecifically to form exo-dig 
syn-products.90 This phenomenon can be explained by the energetically unfavorable transition 
state associated with a hypothetical endo-dig syn-carbopalladation of alkyne 36 (SCHEME 8), 
which would give the highly strained vinylic intermediate 40. The alkyne substituent has in 
some instances been demonstrated as vital for the cyclization.85 Whereas a terminal alkyne of 
41 does not participate in a cyclization event, a methyl group enables the reaction (SCHEME 
8). Similarly, introducing a bulky group at the nitrogen of 41 enabled terminal alkynes to 
participate in the reaction. The necessity of bulky substitutes has been suggested to originate  
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SCHEME 7. Simplified mechanism of an intramolecular tandem Heck-Suzuki reaction. I: Oxidative 
addition, II: Carbopalladation, III: Transmetallation, IV: Reductive elimination. L: Ligand, X: Halide 
or pseudohalide. Formed C-C bonds in bold. 
 
from conformational features of the substrate. A facile carbopalladation require the right 
conformation of 41. 
The 16-electron trans-square planar complex 43 proposed as a product after oxidative 
addition (see chapter 3.1.1) is unreactive in carbopalladations (SCHEME 9).93 However, 
theaddition of acetate ions to preformed complex 43 enables its participation in a reaction 
with styrene. In this reaction, the palladium(II)-complex 44 has been postulated as the active 
species during carbopalladation. Whether other ions, such as hydroxyls, also accelerate the 
carbopalladation is unknown. Further, ligands are well known to affect carbopalladation and 
have in intermolecular Heck reactions been used to tune the regioselectivity between 
branched and linear products.94 Using the literature to elucidate how ligand bulk and 
electronic properties affect carbopalladation of intramolecular addition to alkynes is however 
difficult. 
SCHEME 8. a) Hypothetical endo syn-carbopalladation. b) Influence of substituents on a tandem 
Heck-Suzuki reaction. Substituent bulk presumably force the substrate into a favorable rotamer. 
Formed C-C bonds in bold. 
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SCHEME 9. Ion effect on carbopalladation. While iodide ligated palladium(II)-species 43 react 
sluggishly, acetate ligated species 44 reacts swiftly. 
 
 
3.2 Gold catalyzed annulation of indoles 
Gold(I) is a highly π-acidic metal, a property explained by relativistic effects (which will not 
be theoretically treated here).95 It coordinates strongly with alkynes to give a linear ligand-
gold-alkyne complex 46 (SCHEME 10). The coordination activates the alkyne toward a 
nucleophilic attack, which produces a trans-alkenyl gold complex 47. The nature of the 
nucleophile determines how the gold complex 47 reacts thereafter. It can e.g. rearrange, 
fragment and add additional nucleophiles. This chapter focuses on the reactivity of alkynes 
toward indoles. 
SCHEME 10. Nucleophilic addition to alkynes catalyzed by gold. 
 
Recently, gold catalyzed annulations of indoles have received attention by several research 
groups. Indoles tethered with alkynes at C-2 or at C-3 is a common theme for these 
cyclizations.96-103 The mechanism of gold mediated annulations of indoles can be exemplified 
by a catalytic cycle (SCHEME 11). Treating indoles appended with alkynes in the 3-position, 
e.g. 49, with gold, produces the activated species 50 which readily undergoes nucleophilic 
addition by the indole. A 1,2-shift of the spiro intermediate 51 produce species 52.97, 103 Indole 
52 is the result of a 1,2-shift which retains the initial skeleton connectivity, the 1,2-shift can 
however occur with rearrangement to produce indole 53. Deprotonation regenerates the 
aromatic indole 54, which after protodemetalation produces the target molecule 55 and 
regenerates the gold catalyst.  
Systems comprised of alkynes tethered to indoles via a two atom chain at C-3 have been 
reported to cyclize exclusively into 6-membered rings (SCHEME 12).96, 97, 102, 103 Thus, the 3-
appended indole 56 react via the 5-endo-dig intermediate 57 to give 58 or 59. While 
substrates with two atom tethers have shown only one type of ring-size selectivity so far, 
substrates with four atom tethers have displayed a selectivity which can be controlled by the 
catalytic system.96 A recent investigation into general dig-cyclizations showed that 4-exo is 
kinetically favorable to 5-endo. However, the energy difference is small and the selectivity is  
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SCHEME 11. Simplified mechanism of gold catalyzed annulation of 3-appended indoles. I: Gold-
alkyne coordination, II: Nucleophilic attack, III: 1,2-shift, IV: Deprotonation, V: Protodemetalation. 
L: Ligand 
 
determined by the stereoelectronics of the substrate.104 This suggests that the 3-appended 
indole 56 could be forced into the 4-exo-dig intermediate 60 through careful choice of 
substrate and catalytic system. This would, after a 1,2-shift, produce either the 3-alkenyl-
cyclopenta[b]indole 61 or the 1-alkenyl cyclopenta[b]indole 62. 
SCHEME 12. Reactivity of indoles tethered to alkynes via a two carbon chain.  
 
3.3 Design of experiments (DoE) 
Experiments constitute the core of research. Whenever a research question is investigated, 
experiments are conducted to generate information relevant to the study. Design of 
experiments (or statistical experimental design) is a rational method for designing 
experiments which will produce as much relevant information as possible. More specifically, 
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by investigating variables by their simultaneous variation, an information rich quantitative 
model of the investigated problem is produced.  
3.3.1 DoE, step-by-step 
The workflow of an experimental design, exemplified by an organic reaction, is briefly 
outlined below.  
1) Defining objective and choosing response variables. Before any experiments can be 
conducted, it is important to have a well-defined objective of the study. This is closely related 
to choosing response(s) which are measurable outcomes of the experiments. In a typical 
organic reaction, the objective is often "to obtain as much product as possible" which is 
quantified by the response "yield". 
2) Establishing variables affecting the responses. The variables, also known as factors in 
DoE, can either be varied (investigated) or kept constant (non-investigated) during the 
experiments. As the number of varied factors increase, the experiments necessary to perform 
will rapidly be amplified. Consequently, the varied factors should if possible be limited to the 
most influential and interesting ones. In the present exemplar reaction, temperature (T), 
concentration (C) and time (t) are chosen as investigated variables. 
3) Choosing levels of the investigated (varied) factors. Each factor is typically investigated at 
two levels, a high (+) and a low (-) level. Choosing factor values can be difficult, but initial 
estimates can often be made based on chemical understanding and previous knowledge. In 
this example, we choose: T (+) = 100°C, T (-) = 50°C, C (+) = 1 M, C (-) = 0.1 M, t (+) = 10 
h and t (-) = 1 h. 
4) Choosing an experimental design. The design determines which experiments to perform. 
Each design aims at producing as much high quality data as possible with as few experiments 
as possible. Three related experimental designs are briefly described below. 
4a) Full factorial design. Here, the factors are investigated in all possible combinations. Both 
factor main effects and effects due to factor interactions can be elucidated with a full factorial 
design. The number of experiments necessary to perform is given by 2k where k is the number 
of investigated factors. A center point is also included, which have mid-values on all factors. 
The center point is usually performed three times (triplicate) to determine the experimental 
error. A center point will also reveal whether the response can be modeled with a linear 
function or if the inclusion of higher order terms is required, vide infra. The present example 
with three factors (k = 3) will give 2k = 23 = 8 experiments for factor variations and additional 
3 experiments for the center point, totaling 11 experiments. The explored reaction space can 
be visualized as a cube in a three dimensional coordinate system, confined by the levels of the 
investigated factors (Figure 3). 
With the full factorial design, the reaction model obtained after data fitting has the form: 
ݕ݈݅݁݀ = 	ߚ଴ +	ߚ்ܶ + ߚ஼ܥ +	ߚ௧ݐ + ߚ்஼ܶܥ +	ߚ்௧ܶݐ + ߚ஼௧ܥݐ +	ߚ்஼௧ܶܥݐ + 	ݎ݁ݏ݅݀ݑ݈ܽ														ሺܧݍ. 1ሻ 
Where β0 is a constant, βx are factor coefficients and βxy are factor interaction coefficients. 
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Figure 3. Reaction space visualized as cube defined by the levels of investigated factors (T (+) = 
100°C, T (-) = 50°C, C (+) = 1 M, C (-) = 0.1 M, t (+) = 10 h and t (-) = 1 h.) Each experiment is 
represented by a grey dot. 
Eight coefficients are calculated from the full factorial design, one constant, three for main 
effects, three for second order interaction effects and one for a third order interaction effect. 
4b) Fractional factorial design. Studies based on full factorial designs quickly become 
unrealistic when the number of factors increase; 6 factors = 64 experiments, 10 factors = 1024 
experiments (excluding center point). A large number of variables is also associated with 
many interaction effects of higher order (i.e. interaction effects involving more than two 
factors). The impact of these effects is usually insignificant and does consequently not need to 
be modeled. When excluding higher order interaction effects, a model with 6 factors include 1 
constant, 6 main effects and 16 second order interaction effects, totaling 23 coefficients. Thus, 
23 experiments are enough when excluding interaction effects of higher order, compared to 
the 64 performed in a full factorial design. In the same way, it may be enough to model main 
effects in an initial screening process, which in the case with 6 factors would require 7 
experiments. Fractional factorial designs use a fraction of the experiments needed for a full 
factorial design according to 2k-p where k is the number of factors and p is the size of the 
fraction (i.e. 1/2p = 1/2, 1/4, 1/8... for p =1, 2, 3...). Using a 23-1 fractional factorial design for 
the reaction exemplified here would require 1/21 of the original experiments, i.e. 4 
experiments for factor variation. Another three experiments should be included for the center 
point as discussed previously. The experiments are in a fractional factorial design selected to 
cover a maximal volume of the reaction space (Figure 4).  
With the 23-1 fractional factorial design, a model of 4 coefficients is obtained after data fitting: 
ݕ݈݅݁݀ = 	ܾ଴ +	ܾଵܶ + ܾଶܥ +	ܾଷݐ + 	ݎ݁ݏ݅݀ݑ݈ܽ																																																																																									ሺܧݍ. 2ሻ 
Where b0 is a confounded constant and bx are confounded factor coefficients. 
In Eq. 2, the coefficients are labeled as "confounded", which is an effect of using a fractional 
factorial design. Confounded coefficients are the sums of 2 or more "real" effects and a more 
accurate way of denoting the model would be: 
ݕ݈݅݁݀ = 	 ሺߚ଴ +	ߚ்஼௧ሻ + ሺߚ் + ߚ஼௧ሻܶ + ሺߚ஼ +	ߚ்௧ሻܥ +	ሺߚ௧ +	ߚ்஼ሻݐ + 	ݎ݁ݏ݅݀ݑ݈ܽ																					ሺܧݍ. 3ሻ 
18 
 
 
Figure 4. A 23-1 fractional factorial design with the four experiments covering a maximal volume of 
the reaction space. This can be visualized by projecting the experiments onto lower reaction 
dimensions. Each of the three reaction planes correspond to a full factorial design. 
Where β0 is a constant, βx are factor coefficients and βxy are factor interaction coefficients. 
Thus, the constant term b0 in Eq.2 is really the sum of the "true" constant term, β0, and the 
higher order interaction coefficient, βTCt. It is also seen from Eq. 3 that the main effect 
coefficients are the sum of "true" main effects and second order interaction effects.  
Consequently, if the model contain a large b1, one cannot be certain if it is the temperature or 
an interaction between the concentration and reaction time that strongly affects the yield. The 
confounding is an obvious weakness of the fractional factorial design used here. Moving into 
designs with more factors, fractions become more viable. Using 6 factors in a 26-1 design will 
reduce the number of experiments from 64 to 32 (excluding center point). Yet the main 
effects are only confounded with the fourth order interaction effects and second order 
interaction effects with third order interaction effects. The higher order interaction effects 
rarely contribute and the model terms can reliably be interpreted as main and second order 
interaction effects. 
4c) Central composite face (CCF) designs. As previously mentioned, the center point is used 
to screen for non-linear effects which cannot be modeled with the interaction equations 
obtained from previous designs. The center point, having intermediate values on all factors, 
should consequently have an intermediate response. If the response deviates strongly from 
what is anticipated, it is an indication that quadratic terms need to be included for one or more 
factors. 
Central composite face (CCF) designs are closely related to factorial designs. However, in 
addition to elucidating main and interaction effects, CCF designs investigate quadratic 
relations by isolating and inspecting each of the factors separately. Practically, one factor is 
inspected by performing experiments at its two extreme values, while maintaining the other  
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Figure 5. a) Full factorial 23 CCF design displaying axial points centered on each side of the cube. b) 
The quadratic influence of temperature (T) on the yield is inspected. As the factors C and t are kept 
constant at intermediate values, T can be visualized in a two dimensional coordinate system with 
the response (yield) on the other axis. Notice how the mid-value of 75°C produces the best yield, 
indicating a quadratic dependence of the temperature on the yield. 
factors at intermediate values (Figure 5). For the reaction example with three factors, a CCF 
design requires an additional six experiments to investigate all factors for quadratic relations, 
compared to a factorial design. Once again, a cube can be used to visualize the reaction space 
(Figure 5). The additional experiments are known as axial points and are centered at the sides 
of the cube. Conveniently, factorial designs can easily be evolved into CCF designs by 
introducing axial points.  
With the 23 CCF design, the reaction model obtained after data fitting has the form:  
ݕ݈݅݁݀ = 	ߚ଴ +	ߚ்்ܶଶ +	ߚ஼஼ܥଶ + ߚ௧௧ݐଶ + ߚ்ܶ + ߚ஼ܥ +	ߚ௧ݐ + ߚ்஼ܶܥ +	ߚ்௧ܶݐ +	ߚ஼௧ܥݐ 
+	ߚ்஼௧ܶܥݐ + 	ݎ݁ݏ݅݀ݑ݈ܽ																																																																																																																																		ሺܧݍ. 4ሻ 
Where β0 is a constant, βxx are quadratic factor coefficients, βx are factor coefficients and βxy 
are factor interaction coefficients. 
Fractional factorial CCF designs are also a viable choice. However, the resulting model will 
contain confounded coefficients as discussed above. 
5) Randomizing and running the experiments. Once the experimental design is chosen, the 
experiments are performed in a random order. Experiments run in a randomized order are 
considered to be the most impartial way to obtain reliable data.  
6) Regression and analysis of model. The size of the factor coefficients are elucidated by 
fitting the experimental data by regression. As the resulting empirical model will not fit the 
experimental data perfectly, a residual term (also known as error term) will always 
accompany the model (as is shown in Eq.1 to Eq.4 above). Factors with coefficients that are 
not statistically different from zero (0) have insignificant effects on the response and are 
usually removed from the model.  
Analysis of variance (ANOVA) is the common method for determining the reliability of the 
model. ANOVA make two primary tests. In the first, the total experimental variance is 
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divided into the variance explained by the model and the residual, non-explained variance. A 
good model explains most of the observed experimental variance, thus the residual variance is 
small. In the second test the residual variance is further divided into variance due to model 
error and variance due to imperfect experimental reproducibility. All experiments are 
associated with non-perfect reproducibility, which usually is determined by center point 
replicates in DoE. A good model has a small model error compared to the experimental error, 
which is known as having no lack of fit. Taken together, a good model should have a high 
explained variance compared to the residual variance, and most of the residual variance 
should stem from experimental variance due to imperfect reproducibility.  
There are a number of parameters, obtained from ANOVA, used to evaluate the reliability of 
the model. The explained variation, R2, is a common parameter. R2 adopt values between 0 
and 1, where 1 indicates a model which explain all the variation in the data set and 0 a model 
which does not explain any of the variation. The predicted variation, Q2, is another important 
parameter. It determines how well the model can predict the outcome of new experiments 
within the experimental space. Q2 is determined by cross-validation, in which parts of the 
experimental data is left out during data fitting. Data points corresponding to the data left out 
are then predicted and compared with the experimental data. A Q2 of 1 indicates a model with 
perfect predictability. 
7) Extraction of information from model. With a reliable model in hand, vital information of 
the investigated response can be obtained. In the results and discussion part of this thesis, a 
palladium catalyzed reaction is thoroughly analyzed by DoE and good examples of 
information extracted from the model are given there.  
3.3.2 Strengths of DoE 
Changing one variable at a time (OVAT) is a common approach when investigating reactions 
in organic chemistry. The multivariate approach of DoE has several advantages over the 
classical OVAT approach. Consider an example, where a two factor optimization of a reaction 
is attempted (Figure 6). Using OVAT, the first variable (T) is optimized with regard to  
 
Figure 6. Reaction optimization of two factors (T and C) illustrated with a yield contour map. OVAT 
experiments represented as grey dots and DoE experiments as black dots. Both approaches span 
over an equal reaction space when considering the factors individually, but DoE span a larger area 
due to the even distribution of experiments. 
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reaction yield. With the optimal temperature, the second variable (C) is optimized. This 
method clearly misses important features of the reaction landscape, where a gradient is 
running diagonal to the OVAT coordinate system. With DoE, having experiments evenly 
distributed over the two dimensional reaction space, this feature will be detected. The center 
point is recognized as the highest yielding experiment and the initial 22 full factorial design 
can be evolved into a CCF design. Performing the extra axial experiments will after data 
fitting produce a quantitative model with quadratic terms for both T and C. The model can be 
used to find the exact maximum within the investigated reaction space.  
3.3.3 DoE, discrete variables and principal component analysis (PCA) 
So far, only continuous variables have been discussed. In a typical organic reaction, several of 
the variables are however discrete, e.g. different reagents. Discrete variables can be 
investigated with DoE in a comparative type of study. It is possible to elucidate how the 
discrete variables influence the response, but it will not give any information about other 
"values" of the discrete variable, e.g. investigating two bases in a reaction will reveal their 
effects, but will not give any information to whether a third base would work even better. 
Treating reagents as continuous variables, in which each of the reagents have a specific value, 
would greatly enhance the amount of information obtained from DoE.  
Describing a molecule with a single property is difficult and will likely only provide a limited 
amount of the information necessary to chemically explain it. However, by describing a 
molecule with many properties, either physical (e.g. melting point, retention times in HPLC 
etc.) or calculated (e.g. HOMO, LUMO etc.), a more complete picture of its chemical 
behavior is produced. Each molecular property would however need to be introduced as a 
separate factor in DoE, which would result in a huge number of experiments. As a solution, 
the data processing technique principal component analysis (PCA) can be used to compress 
the dataset while maintaining as much of the original information as possible.  
To explain PCA, a small dataset containing 13 molecules explained by three properties is used 
(Figure 7). PCA recognize the directionality of the greatest variance in the three-dimensional 
dataset and introduce a new variable (known as a latent variable or a principal component) 
oriented in this direction. The original data will be projected onto the latent variable. The 
three dimensions have thereby been reduced to a single dimension, explaining as much of the 
variance (information) in the original dataset as possible. Compressing the data into a single 
dimension does usually not sufficiently explain the original information, whereby more latent 
dimensions are introduced. A second latent variable is introduced orthogonal to the first, and 
oriented to capture as much of the remaining variance as possible. More latent variables can 
be introduced in the same way. Here, a dataset with three-dimensions (i.e. three variables) has 
been described for simplicity. In reality, molecules are explained by many more properties, 
ranging from ten to hundreds of them. The strength of PCA is also best demonstrated when 
this type of multidimensional datasets are compressed into a few orthogonal variables. 
The relation between the original variables and the latent variables can be inspected and used 
to give the latent variables a physical meaning. For instance, if the first latent variable in 
Figure 7 would be highly related to melting point and molecular weight, it may be interpreted 
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Figure 7. 13 compounds explained by their melting points (mp), molecular weights (Mw) and 
number of oxygens (nO). PCA introduce a latent variable, t1, which capture as much of the variance 
as possible within the dataset. The data points (compounds) are projected onto t1. A second latent 
variable, t2 is introduced orthogonal to t1. t2 is oriented to capture as much of the remaining 
variance as possible. The data points are projected onto t2 (not shown) and the dimensionality of 
the dataset has efficiently been reduced from three to two dimensions. The new dimensions 
generate a plane (grey) described by t1 and t2. 
as capturing the size of the molecule.  
For more detailed descriptions of DoE and PCA, the reader is referred to more specialized 
literature.105-113  
3.4 Chemistry of excited states 
Organic molecules can interact with electromagnetic radiation of different wavelengths, i.e. 
photons of different energies. The absorption of a photon (hν) will force the organic molecule 
into an energetic excited state. Depending on the energy of the radiation, the transition can for 
instance be rotational, vibrational or electronic. The latter type of transition is caused by ultra 
violet and visible light, which are in focus here. The absorption process is from a molecular 
perspective instantaneous (10-15s), i.e. not even displacement of the nuclei will occur. Once in 
the excited state, the relaxation back to the ground state is not instantaneous but is sufficiently 
long for molecular processes such as diffusion and conformational changes to transpire.114 A 
few molecular processes affecting the molecular excited state and its relaxation back to the 
ground state are discussed here. 
The Jablonski diagram is a convenient way to represent the most common relaxation 
processes (Figure 8). A molecule in the ground state, denoted S0, can be excited to the first, 
second or even higher electronic states, denoted S1, S2 etc. The concurrent vibrational 
excitations, responsible for the structure of absorption spectra, are also given in the diagram. 
 
Figure 8. Jablonski diagram. IC: internal conversion, ISC: intersystem crossing. 
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Once in the excited state, the molecule is quickly relaxed to the lowest lying vibrational state 
of S1 by internal conversion (IC). The process of IC typically occurs within 10-12s. In the S1 
state, the molecule can emit a photon, i.e. returning to ground state by fluorescence. It can 
also proceed via intersystem crossing (ISC), forming a triplet which can return to ground state 
via emission of a photon, i.e. phosphorescence. Finally, it can return via non-radiative 
processes. There are a number of non-radiative processes, for instance energy transfer by 
collisions with other molecules such as oxygen. Quantum yield is used to relate the rate of 
fluorescence and non-radiative processes according to: 
ܳ = ߁߁ + ݇௡௥ 																																																																																																																																					ሺܧݍ. 5ሻ 
Where Q is the quantum yield, Γ is the rate fluorescent emission, knr is the rate of non-
radiative processes. 
When the quantum yield is close to one, the non-radiative processes are too slow to compete 
with the fluorescence and virtually all absorbed photons are re-emitted as light with lower 
energy.114  
Molecular conformational and isomerical changes are well known to affect the quantum yield. 
In fact, fluorescent probes commonly exhibit fast non-radiative excited state decay via 
conformational changes in solution. When bound to a molecular target, such processes are 
denied resulting in an increased fluorescence quantum yield, efficiently enabling detection of 
the target.114 The relaxation of tetraphenylsilole 63 displays such an environmental dependent 
behavior. While in solution at room temperature, the molecule is non-emissive. However, it 
turns brightly fluorescent when the solution is cooled.115 The behavior is attributed to 
rotational freedom of the phenyl groups, which relax the excited state. As the solution is 
cooled, the rotation will eventually be hindered causing the non-radiative relaxation pathway 
to be turned off. Another classical example is the trans/cis-isomerization of stilbene 64. The 
 
Figure 9. a) Rotational relaxation of tetraphenylsilole. b) trans/cis-isomerization deactivation of 
stilbene. 
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double bond is weakened in the excited state, allowing rotation (Figure 9). Both isomers relax 
swiftly in the excited state by a 90° rotation around the double bond, bringing the potential 
energy surface of S1 close to S0, facilitating a swift non-radiative transition.116 As the 
temperature is lowered, the rotational rate in the excited state will decrease, 
consequentlydecreasing the rate of the non-radiative relaxation pathway. Indeed, fluorescence 
of trans-stilbene is enhanced at lower temperatures.117 
Internal charge transfer (ICT) is another excited state phenomenon encountered in some 
species. After a molecule is excited to S1, it can relax via an ICT to a charge separated state. 
The charge separated state is energetically favorable in the excited state, but unfavorable in 
the ground state, brining S1 and S0 closer together. The fluorescence observed from ICT is 
accordingly of longer wavelengths compared to emission from its neutral state (Figure 10). A 
conjugated electron donating-electron accepting moiety is a typical structural feature for 
molecules displaying ICT (Figure 10). The phenomenon is very environmental dependent, 
with polar solvents stabilizing charge separated molecules and apolar destabilizing. As a 
consequence, molecules usually only display fluorescence from charge separated states in 
polar solvents.114  
 
Figure 10. a) Electron donating/accepting system typical for ICT. A charge separated species can 
form in the excited state. b) Simple Jablonski diagram for the ICT process. 
The different electron distributions observed in ground and excited states indicate that the 
ionization potential of molecules can change upon light absorption. Indeed, phenols are more 
acidic in the excited state. Excited phenols are known to protonate solvents and subsequently 
emit fluorescence from the resulting excited phenoxy species.114, 118 The phenomenon occurs 
in protic media and is especially favored by an aqueous environment. A special case arises in 
amphoteric molecules, e.g. 66, where the phenolic hydroxyl group is conjugated with an 
 
Figure 11. Excitation behavior of amphoteric 6-hydroxyquinolin. 
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imine (Figure 11). The molecule display a complicated excited state behavior which has been 
elucidated with time-resolved spectroscopy.119 In the excited state, a step wise proton transfer 
is observed. First, deprotonation of the phenol produce an expected phenoxy anion 67. A 
subsequent protonation of the imine give the zwitterionic species 68 which is a tautomer of 
the ground state molecule. The tautomer relaxes radiationless to the ground state. The 
observed phenomenon was specific for aqueous solutions. In organic solvents (including 
MeOH), the relaxation was characterized by an intersystem crossing mechanism. 
3.5 Kinase inhibition 
Protein kinases are phosphorylating enzymes involved in cellular transduction pathways. 
Kinases are defined by their ability to catalyze the transfer of a phosphate from adenosine 
triphosphate (ATP) onto a hydroxyl substrate, which are specific amino acids in proteins. 
Depending on the substrates, kinases are usually divided into two subgroups; tyrosine and 
serine/threonine. The enzymes have two major conformations, an active and an inactive. The 
inactive form is converted into the active by selective phosphorylation, which is catalyzed by 
an upstream kinase. Consequently, kinases are substrates to other kinases.120, 121 
Inhibition of kinases has during the last decade received a great deal of attention. The human 
genome codes for more than 500 and almost every signal transduction process is believed to 
be wired through a phosphotransfer cascade.121 Various signaling pathways are deregulated in 
cancers and controlling them externally with selective kinase inhibitors can be used to achieve 
a desired physiological effect. The desired effect is typically to prevent growth, which can be 
accomplished by inhibiting a signaling pathway critical for cancer survival.59, 122, 123 
Kinase inhibitors can be divided into three different types, simply called I, II and III. During 
the phosphate transfer reaction, the ATP binds to a pocket within the enzyme. The purine part 
of ATP is buried in the pocket, forming hydrogen-bonds with the enzyme backbone (Figure 
12). Type I inhibitors are designed to interact with the same binding pocket, thus competing 
with ATP (Figure 13). These inhibitors often try to mimic ATP and usually have a 
heterocyclic ring system occupying the purine binding site. To gain a higher binding affinity 
than ATP, the inhibitors include substituents which interact with additional hydrophobic 
regions of the binding pocket. The ATP-binding pocket is rather conserved and one of the 
biggest challenges with type I inhibitors is to acquire selectivity among the 500 kinases. 
Kinase adaptation is another problem with type I inhibitors. Selective point mutations (single 
amino acid exchange) have been demonstrated to introduce sterically demanding amino acids, 
blocking the hydrophobic binding sites vital for inhibitor-kinase interaction. Nonetheless, the 
 
Figure 12. ATP with hydrogen bonds formed between the purine and kinase backbone. 
26 
 
applicability of this inhibitor type is well appreciated and a number are currently available on 
the market for cancer treatment.121 
While type I target active kinases, type II target inactive (also called DFG out). In the inactive 
form, kinases have an additional hydrophobic pocket adjacent to the ATP-binding site. Type 
II inhibitors bind to this additional pocket in addition to the ATP-site, trapping the kinase in 
its inactive form (Figure 13). Targeting the inactive form has been proposed to furnish more 
selective inhibitors and developing protocols for designing type II inhibitors is an ongoing 
endeavor.124, 125 Type III inhibitors bind outside the ATP-binding pocket, to an allosteric site. 
The binding can induce a conformational change in the kinase, preventing constructive 
interaction with ATP or the substrate (Figure 13). Allosteric inhibitors generally exhibit better 
selectivity than the previously described inhibitor types, as the allosteric sites are kinase 
specific.121 
Scytonemin has been reported to inhibit kinases, albeit with poor selectivity. In a study 
including totally seven kinases, scytonemin inhibited five with similar potency. The mode of 
interaction was investigated in kinetic studies which concluded scytonemin to be a mixed 
inhibitor, i.e. the inhibition has both competitive and non-competitive components.37 
Consequently, scytonemin is not acting purely as a type I inhibitor. 
 
Figure 13. Schematic illustration of different kinase-inhibitor interactions. Kinase (grey), ATP 
(green), inhibitor (red). a) ATP coordinate to the kinase in the absence of an inhibitor. b) A type I 
kinase inhibitor, interacting with the ATP binding pocket and a hydrophobic site within, preventing 
ATP to bind. c) A type II inhibitor binding to an inactive kinase by interacting with the ATP binding 
site and the adjacent hydrophobic pocket. d) A type III inhibitor binding to an allosteric site, 
inducing a conformational change of the ATP binding pocket, preventing ATP to bind. 
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4 Results and discussion 
This chapter presents retrosynthetic analysis of the target molecular structure, followed by an 
account over the synthetic results. Photophysicochemical- and biological studies of the 
synthesized compounds are thereafter presented. Results described in the papers are only 
discussed shortly here and the reader is referred to the papers for more details.  
4.1 Retrosynthetic analysis of target scaffolds 16 and 17 
The retrosynthetic analysis of scytonemin scaffold 16 and nostodione A scaffold 17 have 
numerous solutions. It is worth mentioning that just one possible solution is presented here. 
Also, the retrosynthesis is presented in a condensed form, omitting the synthons and directly 
presenting the equivalent reagents.  
An initial disconnection at C-1 of 16 and 17 produced the common structure 70 (SCHEME 
13). It was anticipated that 70 could be dimerized under oxidative conditions into a reduced 
form of the scytonemin scaffold 16, as well as oxidized into the nostodione A scaffold 17. 
Additionally, it was believed that enolate chemistry could be used to introduce various 
substituents at C-1 of 70, giving other types of synthetic derivatives.  
The synthetic intermediate 70 have several possible disconnections that efficiently simplify 
the skeleton and minimize appendages. For this project, the detachment at C-3a was 
considered promising due to:  
1) several stereo- and regiospecific chemical transformations corresponding to this 
disconnection appeared viable, vide infra. 
2) a further disconnection at the carbonyl carbon revealed a synthon corresponding to the 
commercially available indole-3-acetic acid (74). 
We expected that a number of methods could be used to fuse the cyclopentone onto the 
indole. Introducing a halide in the 2-position of the indole provide a handle to initiate a Heck  
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SCHEME 13. Retrosynthetic analysis of scytonemin scaffold 16 and nostodione scaffold 17 with the 
goal of producing a concise and flexible synthetic route (X = halide). 
 
type reaction. The stereochemistry of the alkene in substrate 71 controls the stereochemical 
outcome of the annulation. A more versatile option is formed when performing the Heck 
cyclization with an alkyne of type 72 instead of an alkene. In this case, the palladium cannot 
undergo β-hydride elimination after cyclization, forming a trapped vinylic palladium 
intermediate (see chapter 3.1.2). Performing the reaction in presence of a transmetallation 
reagent generates a palladium species that instead undergo reductive elimination. When using 
boronic acid derivatives as transmetallation reagent, the reaction is known as a 
tandem/cascade Heck-Suzuki reaction. Considering the huge supply of boronic acid reagents, 
we envisioned this to be a very powerful method for producing numerous 3-alkenyl-
cyclopenta[b]indole-2-one derivatives. Similarly, introducing a hydride source instead of a 
transmetallation reagent, it is possible to introduce a hydrogen in the R1-position (reductive 
Heck reaction). 
As an alternative to palladium catalysis, gold catalysis was also considered. Here, the gold 
will activate the alkyne of 73 toward interaction with the nucleophilic indole system. It is 
therefore not necessary to prepare the indole with a halide, affording a more efficient 
synthesis. However, the flexibility of the synthetic route will be lower as the Z-substituent 
(R2) of the exocyclic double bond is limited to a proton. 
It is interesting to note that the cyclopentanone formation via annulation of a 3-substituted 
indole is analogues to the biosynthesis of scytonemin (see chapter 1.2.3), albeit we propose a 
metal catalyzed reaction instead of an enzymatically catalyzed. 
The 3-alkynyl/alkenyl indoles 71, 72 and 73 required for the annulation were expected to be 
readily synthesized via a nucleophilic substitution on indole-3-acetic acid (74) or a derivative 
thereof.  
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4.2 Synthesis of 3-alkenyl-cyclopenta[b]indole-2-one intermediate 70 (Paper 
I-III) 
From the retrosynthetic analysis, 70 was proposed as a key intermediate in the synthesis of 
both scytonemin and nostodione A (SCHEME 13). Three different approaches for the 
synthesis of 70, all based on annulations of 3-substituted indole derivatives, are presented 
here. These include a cascade Heck-Suzuki sequence, a reductive Heck reaction and a gold-
catalyzed Friedel-Craft reaction. Focus will be on the cascade Heck-Suzuki reaction, which 
offer the greatest possibility for diversity oriented synthesis. 
4.2.1 Cascade Heck-Suzuki reaction (Paper I and III) 
Intermediate 77 required for the proposed cascade Heck-Suzuki reaction was synthesized 
from the commercially available indole-3-acetic acid (74) (SCHEME 14). Here, an initial 
transformation of the acid functionality into the corresponding Weinreb Amide 75 was 
followed by a Lewis-acid activated electrophilic aromatic substitution, introducing an iodide 
in the 2-position of the indole, giving 76. Finally, a substitution at the carbonyl carbon by 
lithium TMS-acetylide gave compound 77 which could be explored in the tandem Heck-
Suzuki reaction. The choice of TMS-acetylene was based on 1) it is a stable, easily handled 
liquid, 2) a bulky substituent on the alkyne has been demonstrated as beneficial during 
palladium catalyzed cyclization on similar substrates85 and 3) the outlook of removing it at a 
later stage to furnish mono-substituted exocyclic double bonds similar to what is found in 
scytonemin and nostodione A.  
SCHEME 14. Synthesis of starting material for the cascade Heck-Suzuki reaction. 
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Initial reaction conditions were based on studies from the Fu laboratory and involved a 
palladium(0) precatalyst and a sterically demanding phosphine ligand. The system has 
previously been applied successfully to both Heck and Suzuki reactions.126-128 However, 
treating substrate 77 with phenylboronic acid and the catalytic system only produced minimal 
amount of product, while consuming the starting material (TABLE 1, entry 1). Transforming 
the ketone to a ketal (SCHEME 14) produced substrate 78 which was more compatible with 
the reaction conditions (entry 2). A possible explanation resides either within the electronic 
nature of the alkyne or the steric properties of the ketal. Compared with the electron poor 
alkyne in 77, the alkyne in 78 can potentially form a more constructive interaction with the 
electron deficient palladium(II) species obtained after oxidative addition.  
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TABLE 1. Initial investigation of tandem Heck-Suzuki sequence for the construction of 
intermediate 70. 
 
Entry Substrate H2O equiv. Ar Product Yield 
1 77 0 Ph 79 13% 
2 78 0 Ph 80a 70% 
3 78 0 Ph 80a 30%a 
4 78 1 Ph 80a 72%b 
5 78 1 4-OMe-Ph 80b 30% 
aReaction run on a 50mg scale bReaction run on a 500mg scale. 
Interestingly, we had problems with reproducing this result on a larger scale. Going from 50 
mg substrate (entry 2) to 500 mg (entry 3) reduced the conversion considerably, leaving most 
of substrate 78 unreacted, and consequently resulting in a low yield. The observed difference 
in reactivity was ascribed to water, which proved to have an essential effect on the reaction. 
We attempted to run the reactions anhydrous during the first experiments (entry 1-3), but were 
apparently not able to eliminate water completely. Small scale reactions are for experimental 
reasons prone to contain higher concentrations of water than large scale reactions, which 
explain the scale-dependent reactivity. Running the experiment again, but this time with the 
addition of water (entry 4) resulted in a much more active reaction. The observations agree 
with recent reports on the impact of water in Suzuki reactions as well as the influence of ions 
in Heck reactions (see chapter 3.1). 
The possibility of producing different derivatives simply by using different boronic acid 
reagents is a great advantage with this reaction. However, already when switching from 
phenylboronic acid to the closely related para-methoxy derivative, a significant impact on the 
reaction outcome was observed (entry 5). One reason was the formation of 2-aryl substituted 
indole (of type 84, SCHEME 15), which originates from a pure Suzuki cross-coupling 
between substrate 78 and the boronic acid. The compound 84 is produced when the 
intermolecular transmetallation of intermediate 81 competes efficiently with the 
intramolecular carbopalladation, and the reductive elimination of 83 is faster than the 
carbopalladation. The reductive elimination is rarely the rate limiting step and the direct 
coupling is likely due to the competing reactions of 81. 
To make the reaction a viable option for diversity oriented synthesis, further reaction 
optimization was clearly needed and a Design of Experiments (DoE) investigation was 
pursued (see chapter 3.3). The objective of the study was to obtain reaction conditions 
working with a variety of boronic acids. The measured response was the ratio between yield 
and conversion (y/c), representing how much starting material that is converted to product. 
The response will not discard reactions with low yields as poor if the byproduct formation is  
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SCHEME 15. Possible routes to byproduct formation. 
 
low, i.e. the conversion is similar to the yield. The conversion can often be increased simply 
by using longer reaction times or higher catalyst loading.  
A detailed list over variables anticipated to affect the reaction is presented in paper III. Six 
variables were investigated while maintaining the others at constant values. To model a 
diversity oriented reaction, the electronic property of the boronic acid was introduced as one 
variable. The Hammett constant (Ham) of para-substituted phenylboronic acids was used to 
explain the electronic properties (Figure 14). Concentration (C) and the amount of boronic 
acid (Bor) were introduced as variables to tune the relative rate between carbopalladation and 
transmetallation, since the first is intramolecular and latter is intermolecular. To avoid the 
direct-coupled byproduct (SCHEME 15) the rate of carbopalladation should be higher than 
the rate of transmetallation. Further, water has been demonstrated to affect the reactivity, 
which steered us to opt for the amount of water (H2O) as another variable. Ligands are well 
known to strongly affect catalytic reactions (see chapter 3.1). As discussed in chapter 3.3.3, 
discrete variables such as the ligand can efficiently be introduced in DoE as latent variables 
obtained from principal component analysis (PCA). Jover et al. recently published PCA of a 
P-donor ligand dataset comprising 348 ligands described by 28 quantum mechanically 
calculated descriptors (properties).129 The two first latent variables (t1 and t2) explain 65% of 
the variance and were here used to describe the ligands. By inspecting the relations between 
descriptors and latent variables, Jover et al. described t1 to roughly capture the electronic 
properties and t2 to roughly capture the size of the ligands (large t1: electron rich, small t1: 
electron deficient, large t2: small ligand, small t2: large ligand). Four ligands, forming a 
rectangle covering a major part of the ligand space were chosen, together with an additional 
ligand for the center point (Figure 15). The selection procedure resulted in an array of ligands  
 
Figure 14. Boronic acids used in the DoE study to model the influence of electronic properties, 
quantified by the Hammett constant (Ham). 86 and 88 are used as extreme values and 87 as the 
center point. 
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Figure 15. Ligand space described by two latent variables, t1 and t2. according to Jover et al. 
Initially chosen ligands are represented by green dots and ligands complemented to investigate 
quadratic effects as red dots. 
varying from the universal triphenylphosphine to the bulky, electron rich biaryl phosphine to 
a more unorthodox electron deficient phosphite. As the ligand required two descriptive 
variables, the number of investigated factors were totally six.  
A 26-1 fractional factorial design was chosen for the initial investigation, which efficiently 
reduce the number of experiments to 32 from 64 necessary in a full factorial design. The 
design still allows both main and second order interaction effects to be elucidated with high 
confidence. Nine additional experiments were included to determine the experimental error, 
totaling 41 experiments (for a thorough explanation of included experiments, see supporting 
information for paper III). The experiments were run in a randomized order and analyzed with 
HPLC using external calibration curves, as well as NMR using an internal standard. The two 
analysis methods agreed well, indicating a reliable readout of the reaction. However, multiple 
linear regression could not fit a linear interaction model to the experimental data. Considering 
the high response of the center point, this is hardly surprising (Figure 16). As discussed in 
chapter 3.3.1, the center point should have an intermediate value to fit a linear model. Thus, 
the outcome of the initial 41 experiments prompted us to investigate possible quadratic effects 
and a central composite face design was adopted.  
Axial points for the Hammett constant, the concentration, the amount of boronic acid and the 
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Figure 16. a) Replicate plot of performed experiments. Replicates of the center point in red. b) 
Evaluation of model performance after transforming the response according to e2(y/c) . c) Significant 
factor coefficients at 95% confidence level. 
amount of water were introduced in an ordinary manner, i.e. adopting extreme values on the 
variable investigated for quadratic effects, while maintaining intermediate values on the other 
variables. Axial points for the ligand variables, t1 and t2, required four additional ligands to 
be investigated (Figure 15). After randomizing, executing and analyzing the additional 17 
experiments, a satisfactory model was acquired by introducing a quadratic t1 term and 
transforming the response according to e2(y/c) (Figure 16). The model explained 88% of the 
observed variation, displayed good predictive power and was only accompanied by a small 
model error. Introducing other quadratic terms (e.g. t22 and Bor2) produced inferior models.  
By dissecting the model, information related to reaction performance could be acquired. It is 
clear that the ligand is the most influential of the investigated factors. All but one of the 
significant effects include a ligand variable. The combination of negative coefficients for t12 
and t1 indicate that electron neutral to slightly electron deficient ligands are favored. Further, 
the negative t2 effect signifies that large ligands are preferred over small. The pure ligand 
effects are easiest visualized with response surface maps (Figure 17). Complementary to the 
pure ligand effects, the model revealed interesting ligand interaction effects. The interaction  
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Figure 17. Response surface maps displaying the effects of t1 and t2 on the response for a) Ham = 
0.54 and b) Ham = -0.27. The initially chosen ligands (represented as green dots in the two 
dimensional ligand space) are projected onto the response surface. The optimal ligand tris(4-
trifluorophenyl)phosphine (89) is represented as a purple dot. 
between t1 and Ham point toward a preference for electron deficient ligands when using 
electron poor boronic acids and electron rich ligands when using electron rich boronic acids 
(Figure 18). This subtle interaction effect is however largely surpassed by the overall reaction 
preference for electron neutral ligands. The combination of Bor and the interaction between 
Bor and t1 indicate an overall favorable effect of high boronic acid loadings, but together with 
increasingly more electron rich ligands, the positive effect is diminished (Figure 18). The 
other investigated variables had insignificant effects on the reaction.  
To maximize the amount of product, the substrate need to follow the right reaction pathway 
(SCHEME 15), which is controlled by the relative rates of carbopalladation, transmetallation 
and reductive elimination. Oxidative addition to a carbon-iodide bond is fast and it should 
consequently not affect the reaction. To tune the complex reaction path, we investigated a 
number of variables with DoE. In particular, we envisioned that controlling the relative 
carbopalladation/transmetallation rate would be the key to an efficient reaction, and therefore 
investigated the reaction concentration and the loading of boronic acid. However, the first 
variable had an insignificant effect and the latter a minor. Instead, we found that the reaction 
outcome was controlled almost completely by the ligand. The reaction model revealed a 
complex relation between ligand and response, where steric and electronic properties of the 
ligand affected the reaction both linearly and quadratically. The ligand should be large but 
neither too electron rich, nor too electron poor to properly guide the substrate through the 
correct reaction pathway. As large ligands are favored, it is possible that mono-ligated 
palladium complexes are involved in the reaction. Larger ligands favor mono-ligated 
palladium, while smaller are more prone to exist as bi-ligated complexes.  
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Figure 18. Calculated interaction effect plots for a) Ham × t1 and b) Bor × t1 at mid values on the 
other factors. 
The optimal ligand also depended on the amount of boronic acid and its electronic properties, 
indicating that these reaction variables affect the relative rate of the catalytic steps. Indeed, a 
high loading of boronic acid will increase the rate of transmetallation. Accordingly, an 
optimal ligand should demonstrate an antagonistic effect, restoring the transmetallation rate to 
its native, slower state. When using increasingly higher boronic acids loadings, the model 
predicts optimal behavior from ligands with increasingly more electron deficient 
characteristics, i.e. electron poor ligands should decrease the transmetallation rate. The 
boronic acid electronic properties are harder to rationalize as both the rate of transmetallation 
and reductive elimination are affected.76 However, it has been proposed that electron poor 
boronic acids increase the rate of transmetallation and as discussed above, the ligand should 
counteract the increased rate. When using increasingly more electron poor boronic acids, the 
model predicts optimal behavior from ligands with increasingly more electron deficient 
characteristics, i.e. electron poor ligands should decrease the transmetallation rate. Taken 
together, both interaction effects propose reduced transmetallation rates from ligands with low 
t1, i.e. electron deficient. Interestingly, a computational study recently proposed electron 
deficient ligands to accelerate transmetallation, contradictory to what is argued above.72 There 
are several possible reasons for the divergent observations. Firstly, it is important to point out 
that t1 has been assumed to account for purely electronic effects during the discussion. This is 
not true, as it also explains steric properties of the ligand to some degree. Hence, care should 
be taken when discussing latent variables as pure physical properties. Secondly, the 
electronics of the boronic acid will affect several of the catalytic steps, not just 
transmetallation. Although we cannot be sure of the underlying mechanism explaining the 
observed ligand influence, the model can be used to find optimal reaction conditions. 
As discussed above, the ligand was the most crucial component of the investigated reaction, 
and consequently the most important parameter to optimize. Response surface maps were 
used to guide the choice of a ligand applicable to both electron rich and electron poor 
substrates (Figure 17). There are unfortunately no commercial ligands at the top of the 
parabolas, but the electron deficient tris(4-trifluorophenyl)phosphine (89) was in close 
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proximity. The model also predicts high loadings of boronic acids to be slightly beneficial. 
However, the benefit needs to be balanced against the cost, which can be rather high for 
certain boronic acids, and 1.5 equivalents were used in subsequent experiments. Intermediate 
values were used for the non-influential variables. 
Optimal reaction conditions thus consisted of the precatalyst Pd2(dba)3, the ligand tris(4-
trifluorophenyl)phosphine, boronic acid (1.5 equivalent), H2O (2 equivalents), Cs2CO3 (2.5 
equivalents), and 1,4-dioxane (0.06 M with regard to substrate) at a temperature of 50°C. 
The optimal reaction conditions were assayed in a scope and limitation study, in which totally 
20 boronic acids were tested (see paper III for full details). The reaction had some clear 
limitations. Firstly, strong electron withdrawing substituents conjugated with the reactive 
center (the B(OH)2 substituted carbon) did in most cases not produce sufficient material to be 
isolated. Secondly, ortho-substituted aryls were too sterically congested to constructively 
participate in the reaction. Thirdly, coordinating groups such as phenols and carboxylates did 
either not react at all or only produced minor amounts of products. Apart from these 
limitations, the reaction proceeded well with various phenyl derivatives, thiophenes and 
pyridines. 
The obtained derivatives could be transformed into the desired fragment 70 in moderate to 
good yields by acetal hydrolysis under acidic conditions followed by TMS-excision using 
TBAF in THF (SCHEME 16, see paper III for full details). Interestingly, the compounds 
isomerized spontaneously around the exocyclic double bond after removing the silyl group, 
and a thermodynamic equilibrium mixture of isomers was obtained. The equilibrium strongly 
favored the original configuration with less than 2% of the Z-isomer observed in most cases. 
However, when the double bond was conjugated with a strongly electron withdrawing group, 
SCHEME 16. a) Final steps in the synthesis of fragment 70 via the tandem Heck-Suzuki route. b) 
Observed isomeric equilibrium of fragment 70. c) HOMO-LUMO of 70b with arrows pointing to the 
exo-cyclic double bond.  
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the equilibrium shifted into an equal distribution of isomers (SCHEME 16). The isomerization 
mechanism was investigated with quantum mechanical excited state calculations using time-
dependent DFT. The strongest electronical transition for 70b was predicted to 419 nm and 
corresponded to a pure HOMO-LUMO transition. Examining the molecular orbitals, the 
double-bond is characterized by a binding π -orbital in HOMO, while LUMO adopts an anti-
bonding π-orbital (SCHEME 16). A HOMO-LUMO excitation should consequently reduce 
the bonding order of the double bond, potentially weakening it enough to allow an 
isomerization process. 
Another observed structure-activity phenomena concerned fluorescence, which was highly 
dependent on the para-substituent of the phenyl ring. While a para-methoxy substituted 
compound displayed weak fluorescence, a para-chlorinated was brightly fluorescent (visually 
observable). All attempts to quantify the fluorescence (measure quantum yields) were fruitless 
due to observable changes in the absorption spectrum and to emission intensity during 
measurements. We hypothesize that the spectral changes are related to the E/Z-isomerization 
process described above, but further studies are necessary to elucidate the observed 
photophysical behavior.  
4.2.2 Reductive Heck reaction (Paper II) 
The reductive Heck strategy was originally intended for synthesizing the unnatural 
stereoisomer of scytonemin. As the project progressed, it soon became apparent that the 
ketone conjugated exocyclic double bond isomerized spontaneously under ambient conditions 
to the thermodynamically most stable isomer, as previously described (see chapter 4.2.1). 
However, the reductive Heck methodology can still be used as a complement to the cascade 
Heck-Suzuki reaction. 
Starting materials were synthesized by nucleophilic substitution at the carbonyl carbon of 
Weinreb amide 76 (SCHEME 17). Treating 76 with phenylethynyl lithium gave ketone 89a. 
The same reaction using (4-methoxyphenyl)ethynyl lithium resulted in unstable product 89b, 
which spontaneously oxidized into spiro-indolinone 91. However, treating 89b with NaBH4/ 
SCHEME 17. Synthesis of starting materials for the reductive Heck cyclization reaction. 
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EtOH directly after workup gave alcohol 90b as a stable intermediate. The same method 
could be used to synthesize precursor 90d, which likewise was unstable as a ketone. The 
alcohol 90a was also constructed for comparison. The regeneration of the ketone functionality 
was anticipated to be conceivable after cyclization of alcohol precursors 90a, b and d. 
Subjecting alcohol 90b to typical reductive Heck conditions130-134 (TABLE 2, entry 1) gave 
the desired product 92b together with a number of uncharacterized byproducts. Switching 
solvent from THF to DMF gave better selectivity, resulting in a higher yield and less 
byproducts (entry 2) We have not been able to rationalize the observed difference in 
selectivity between DMF and THF. The TIPS-protected substrate 90d was ring closed under 
the same reaction conditions (entry 3). TIPS-groups can be removed under mild and selective 
conditions to give free hydroxyl groups,135-138 which could be utilized in the synthetic 
endgame of scytonemin and nostodione A. Unfortunately, the TIPS-group was slightly too 
labile for the developed reaction conditions, giving a mixture of the desired product 92d and 
its TIPS-cleaved counterpart 92e. Finally, ring-closing ketone 89a resulted in a low yield 
(entry 4), similar to what was observed for the tandem Heck-Suzuki reaction (see chapter 
4.2.1). 
In a recent report, a procedure involving acetate salts in DMF has been used to cleave 
phenolic silyl ethers.137 Based on this study, the acetate ions from the precatalyst and the 
formate ions used as hydride source both seemed likely to cause TIPS-excision in the 
reductive Heck reaction. Consequently, the applicability of another precatalyst and other 
hydride sources were investigated. Initially, promising results were obtained when treating 
substrate 90a with the previously developed reaction conditions but in the presence of another 
precatalyst, Pd(PPh3)2Cl2 (TABLE 3, entry 1). Next, to exclude the presence of formate ions, 
different hydride sources were tested. The use of phenylsilane (entry 2), proton sponge (entry 
3) and Hantzsch ester (entry 4) as sources of hydrides have previously been reported in 
reductive Heck reactions,139, 140 while 1,4-cyclohexadiene (entry 5) is a wild-card. 
TABLE 2. Initial studies of the reductive Heck reaction. 
 
Entry Substrate Pd(OAc)2 PPh3 Solvent Product E/Z Yield 
1 90b 0.2 equiv. 0.4 equiv. THF 92b n.d. 44% 
2 90b 0.2 equiv. 0.4 equiv. DMF 92b 1:10 90% 
3 90d 0.2 equiv. 0.4 equiv. DMF 92d/ea 1:9 78% 
4 89a 0.1 equiv. 0.2 equiv. THF 70a n.d. 15% 
 a28 % with TIPS and 50 % without TIPS. 
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TABLE 3. Screening of different hydride sources for the reductive Heck reaction. 
 
Entry Precatalyst Hydride source Temp. Et3N Yielda 
1 Pd(PPh3)2Cl2 HCOOH 60°C 3 equiv. 75% 
2 Pd(PPh3)2Cl2 Phenylsilane 60°C 2 equiv. 9% 
3 Pd(PPh3)2Cl2 Proton sponge 60°C - 0% 
4 Pd(PPh3)2Cl2 Hantzsch ester 60°C 2 equiv. 0% 
5 Pd(PPh3)2Cl2 Cyclohexadiene 60°C 2 equiv. 0% 
6 Pd(OAc)2/(PPh3)2 Proton sponge 95°C - 6% 
7 Pd(OAc)2/(PPh3)2 Hantzsch ester 95°C 2 equiv. 8% 
a Yield measured by NMR against 1,3,5-trimethoxybenzene and hexamethylbenzene as internal 
standards. 
Only phenylsilane did actively participate in a constructive manner, albeit yielding a limited 
amount of product 92a. When increasing the temperature and using Pd(OAc)2 as precatalyst, 
the protons sponge (entry 6) and Hantzsch ester (entry 7) produced the desired product, but 
also in very poor yields.  
Of the tested hydride sources, none could compete with formic acid. Phenylsilane has been 
reported to operate via a radical mechanism and a mechanistic comparison with formate ions 
is therefore difficult. However, both the proton sponge and the Hantzsch ester likely work 
mechanistically similar to formate ions in the hydride delivery step, and their incompatibility 
was slightly surprising. Some speculative explanations to the observed outcome can however 
be made. First, the sluggish proton sponge reaction may be rationalized by thermodynamical 
considerations. The generation of gaseous carbon dioxide is a strong entropic driving force 
when using formates (SCHEME 18a). The formation is likely also a strong enthalpic driving 
force. The proton sponge form oxidation product 96 which is neither as enthalpically nor 
entropically favorable as carbon dioxide (SCHEME 18b). On the other hand, the Hantzsch 
ester oxidation has a good driving force, going from a non-aromatic system to an aromatic 
(SCHEME 18c). The poor reaction outcome can potentially be ascribed to the allyl anion 
formation required for β-hydride elimination. The allyl anion 98 can only be formed by an 
initial nitrogen-palladium coordination and a subsequent deprotonation by Et3N. The 
palladium-nitrogen coordination is inherently weak, which is further amplified by the 
deactivating ester substituents of the Hantzsch ester. Consequently, complex 97 is likely only 
a minor species, resulting in a slow formation of the allyl ion species 98. This can be 
compared to formates and the proton sponge which can β-hydride eliminate without any 
external involvement. 
It should be noted that each hydride source has been tested in a limited part of the reaction 
space and that suitable conditions could likely be obtained in a more thorough study, taking  
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SCHEME 18. Comparison of the hydride transfer step using a) formate ion, b) proton sponge and c) 
Hantzsch ester. 
 
other reaction parameters, such as solvents, ligands, and bases, into account. This could 
preferentially be done with DoE. 
The syntheses of fragment 70 derivatives b, d and e were completed by oxidation of the 
hydroxyl group (SCHEME 19). Several conditions were tested for this final functional group 
transformation. Due to the oxidation-sensitive nature of indoles, most of the conditions (e.g. 
Swern and Dess-Martin) simply degraded the starting material. Finally, we found that the 
Shvo catalyst (101) selectively oxidized the hydroxyl under Oppenauer-type reaction 
conditions.141-143 The so formed ketones in their Z isomeric forms spontaneously isomerized 
to the favorable E-isomers as anticipated. Interestingly, we noticed that compound 70e 
isomerized at a much higher rate compared to 70b and d. While the isomerizations of 70b and 
SCHEME 19. Final step in syntheses of fragment 70 via the reductive Heck route. 
 
41 
 
70d are likely limited to light driven processes, the free hydroxyl allows compound 70e to 
tautomerize into 100, which can rotate around the exocyclic bond and then tautomerize back 
into the E-isomer (SCHEME 19). The co-operation of two mechanisms may explain the 
increased isomerization rate. 
4.2.3 Gold catalyzed Friedel-Craft annulation (Unpublished) 
A last strategy for obtaining key intermediate 70 used the alkynophilic properties of gold in a 
catalytic Friedel-Craft type of aromatic annulation. Efficient use of this reaction would give a 
concise route to the molecular target. However, we realized that the annulation offered a 
double challenge in terms of selectivity. First, the initial cyclization needs to form the 4-exo-
dig spiro intermediate regioselectively, a reactivity which has not been encountered 
previously (see chapter 3.2). Secondly, the spiro intermediate need to proceed via a selective 
1,2-shift to form the 3-alkenyl-cyclopenta[b]indole-2-one and not the 1-alkenyl counterpart. 
Two different model substrates were synthesized to investigate the selectivity of the reaction. 
Substrate 102 was obtained by nucleophilic substitution at the carbonyl of Weinreb amide 75 
(SCHEME 20). It seemed likely that the α,β-unsaturated system of alkynyl ketone 102 would 
direct the nucleophilic attack toward a classical Michael addition, giving the undesired 
regioisomer. The ketone 102 was therefore reduced into alcohol 103. 
SCHEME 20. Synthesis of starting materials for the gold-catalyzed Friedel-Craft annulation. 
NaBH4,
EtOH, 0 °C
NH
O
102
NH
HO
34% yield
103
NH
N(OMe)MeO
75
Li
THF, -78° to rt
80% yield
 
Three stereoelectronically different commercially available gold catalysts (SCHEME 21) 
were used together with alkynyl ketone 102 in a small screening study. The catalysts ranged 
from the very bulky 106 and 107, to the less sterically demanding 108. The electronics ranged 
SCHEME 21. Screening of different gold catalysts for the annulation of 102. 
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0.1 106 : 35% yield
0.1 107 : 68% yield
0.1 108 : 45% yield
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from the electron rich phosphine complex 107 to the more electron poor phosphite 106 to a 
gold species in a higher oxidation state, 108. We observed varying efficiencies between the 
catalysts, with 107 giving the best result and 106 the worst. Unfortunately, all experiments 
exclusively produced six membered rings instead of the desired five membered ring-closed 
product 104. The cyclization was followed by a keto-enol tautomerization to give 105, which 
belongs to another class of natural products, namely carbazoles. We noted that the 1,2-shift 
proceeded with retention of the initial skeleton arrangement, i.e. the carbon connected to the 
indole in substrate 102 did not migrate in the 1,2-shift. 
Next, alkynyl alcohol 103, which lack the Michael acceptor functionality of 102, was used as 
substrate (SCHEME 22). As previously discussed, the electronic preference to form 5-endo-
dig spiro intermediates was hypothesized to be lower for this substrate. However, no change 
in the ring-size selectivity was observed, neither with 107 nor 108 as catalysts. An aromatic 
carbazole was instead obtained by dehydration of the alcohol. It is worth noting that the 1,2-
shift proceeded exclusively with retention of the initial skeleton arrangement in all cases, a 
reactivity pattern which has recently been reported as completely reversed for a similar 
substrate.103 
SCHEME 22. Gold catalyzed annulation of 103. 
 
4.3 Total synthesis of nostodione A (Paper II) and scytonemin monomers 
(Paper IV) 
The synthesis of nostodione A was anticipated to be achieved via a Yonemitsu oxidation144 of 
a 3-alkenyl-cyclopenta[b]indole-2-one derivative (70). The Yonemitsu reaction use DDQ to 
oxidize the indole into an α,β-unsaturated imine of type 110 (SCHEME 23). A succeeding 
attack by water form 111 and an additional oxidation establish the dione functionality present 
in nostodione A. Compound 70d obtained via the reductive Heck route was expected to 
furnish nostodione A via a Yonemitsu oxidation and a succeeding mild deprotection. 
Submitting 70d to standard Yonemitsu reaction conditions, using DDQ in a THF/H2O solvent 
system, produced only trace amount of product. Through the course of reaction optimization, 
we found a strong solvent dependence and switching to MeCN/H2O furnished the desired 
product 112 in good yields (SCHEME 23). A final deprotection using TBAF yielded 
nostodione A. Compound 70e, having a free phenolic hydroxyl group, was not compatible 
with the Yonemitsu conditions. However, it could be reprotected in excellent yield using 
TIPSCl and then transformed into nostodione A. In this way, all the product obtained from the 
reductive Heck reaction of 90d (TABLE 2) could be funneled into nostodione A.  
While investigating the Yonemitsu reaction, DDQ in THF was found to efficiently oxidize 
70d. However, the subsequent attack by water on the formed α,β-unsaturated imine was very  
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SCHEME 23. a) Synthesis of nostodione A from compound 70d and e, obtained from the reductive 
Heck route. b) Tentetative mechanism for the Yonemitsu oxidation. 
 
slow. The observed reactivity was realized when α,β-unsaturated imine 110d was isolated 
from the reaction mixture (SCHEME 24). Possibly, MeCN has a stabilizing effect on the 
polarized electrophilic-nucleophilic transitions state during the addition of water, 
consequently lowering the reaction energy barrier. Although isolation of the enimine 
intermediate was not the desired result, it was none the less a pleasing outcome. The 
compound is the monomeric counterpart of scytonemin and in that sense interesting for 
photophysical studies. The direct comparison between monomer and dimer can potentially 
give information to the relaxation behavior of scytonemin. For this purpose, two more 
monomers were synthesized (SCHEME 24). 
SCHEME 24. Synthesis of scytonemin monomer derivatives. 
 
a Solvent was THF/H2O 9:1 for 70d 
4.4 Total synthesis of scytonemin (Paper I) 
In the retrosynthetic analysis, the dimeric structure of scytonemin was anticipated to be 
synthesized via oxidative coupling of two monomer fragments. Oxidative coupling of lithium 
enolates and silyl enol ethers are well documented in the literature and were envisioned as a 
possibility.145-151 Indeed, deprotonation of monomer 70a with LDA and sequential treatment 
with an oxidant formed the dimeric compound 113a as an inconsequential mixture of  
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SCHEME 25. a) Oxidative enolate dimerization and subsequent oxidation.b) Suggested mechanism 
for the oxidative enolate coupling using iron(III). 
N
ON
O
NH
OHN
O
H
H
NH
O
R
R
R
1) LDA, THF, -78°
2) FeCl3, DMF -78° to rt
DDQ, THF,
0°C R
R
70a : R1 = H
70b : R1 = OMe
70c : R1 = NO2
70d : R1 = OTIPS
70f : R1 = OPMB
113a : R1 = H, 56% yield
113b : R1 = OMe, 70% yield
113c : R1 = NO2, 0% yield
113d : R1 = OTIPS, 52% yield
113f : R1 = OPMB, 59% yield
16a : R1 = H, 65% yield
16b : R1 = OMe, 69% yield
16d : R1 = OTIPS, 92% yield
NH
O
R
Li
Fe(III)
NH
O
R
(II)Fe
Li
R
O
HN
NH
OHN
O
H
HR
R
Li
O
NH
OHN
O
H
HR
R
114 115
116 113
a)
b)
 
diastereoisomers (SCHEME 25). Four different oxidants were screened (please see paper I). 
Irontrichloride clearly outperformed the other oxidants and was used for the remainder of the 
study. Oxidative couplings involving iron(III) have been suggested to proceed via a single 
electron transfer (SET) mechanism, where an initial transmetallation between lithium and iron 
forms complex 115 (SCHEME 25).146 The complex can be seen as an oxidized enolate with a 
single electron delocalized over the four atom system. The oxidation converts the nucleophilic 
enolate into an electrophile, which can react with a lithium enolate forming radical 116. 
Another oxidation by iron(III) give the desired dimer 113.  
The coupling strategy was also applied to the electron rich monomer 70b, which worked even 
better than 70a. On the other hand, applying the method to electron deficient monomer 70c 
yielded no product at all. The strong influence by the electronic properties concur with 
published reports.146 Three additional dimeric compounds with different phenolic protective 
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groups were synthesized through the course of the project. Further, the diastereoisomeric 
mixtures could be oxidized by DDQ, forming single compounds containing the scytonemin 
core skeleton (16) (SCHEME 25). 
The synthetic endgame of scytonemin did to a large extent revolve around the phenolic 
protective group. The dimeric compounds proved to be sensitive toward both basic and acidic 
reaction conditions, and most protective group excision strategies resulted in decomposition. 
First, we used borontribromide on compound 16b (SCHEME 26). However, the attempted 
methyl group excision was unsuccessful due to severe decomposition. The reduced form 113b 
proved to be more stable and submitting it to the same conditions gave phenolic compound 
113e, albeit in a mixture with many uncharacterized byproducts. Nonetheless, DDQ oxidation 
and preparative HPLC yielded scytonemin, but as expected in low yields.  
Para-methoxybenzyl protective groups, which can be removed by DDQ and water, were 
investigated next. As DDQ was found to efficiently oxidize the isomeric mixture into the 
desired scytonemin skeleton, we envisioned that compound 113f could be transformed into 
scytonemin by a single operation (SCHEME 27). Unfortunately, the strategy was 
unsuccessful and resulted in substrate decay. Substrate 113f could however be deprotected 
with borontribromide and oxidized into scytonemin, although without increasing the yield 
compared to the methyl protective group (SCHEME 26). 
With the moderate success of removing ether groups, we were inclined to investigate a more 
labile precursor. Considering the successful synthesis of nostodione A, a TIPS-protected 
derivative was investigated (SCHEME 28). The TIPS-excision was attempted from both the 
reduced and oxidized form with the latter being most successful. Using a more labile 
SCHEME 26. Synthesis of scytonemin from ether precursors. 
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SCHEME 27. Unsuccessful attempt to combine oxidation and PMB-excision. 
 
protective group was indeed more productive, with less product decay compared to methyl 
and PMB protective groups. 
SCHEME 28. Synthesis of scytonemin from a TIPS-protected precursor. 
 
4.5 Photophysicochemical behavior of scytonemin (Paper IV) 
Scytonemin (1) is well known to protect cyanobacteria from UV-light. In fact, its 
accumulation in the extra cellular sheaths allows the bacteria to thrive in locations highly 
exposed to solar radiation.8 Further, scytonemin is proposed to be an ancient metabolite, 
suggesting inherent optimal traits which cannot be improved upon by the evolutionary 
mechanism.18 It is often referred to as photo-stable and has been reported to be non-
fluorescent, which taken together indicate inherently fast non-radiative relaxation processes.8, 
17, 19 Despite these traits, interesting for the development of sunscreens, the photophysics of 
scytonemin has yet been left almost completely unexplored. Against this background, we 
initiated a study of the photophysical behavior of scytonemin. 
Scytonemin is a fairly complex molecule and several possible excited state deactivation 
mechanisms contributing to the non-emissive S1 → S0 relaxation can be envisioned. These are 
discussed theoretically in chapter 3.4. First, there are several possible conformational changes. 
Rotation around single-bonds will affect the conjugated system and can possibly affect the 
excited state behavior (Figure 19). Further, the exocyclic double-bond could potentially 
participate in a stilbene type of deactivation, isomerizing between cis and trans 
configurations. There are also electron donor/acceptor moieties, which could be involved in 
internal charge transfer processes. Finally, the phenol group is likely to become much more 
acidic upon excitation, forming a phenoxy anion 1b under neutral aqueous conditions. The 
particular amphoteric structure of scytonemin allows further protonation, forming an excited 
tautomer 1c in analogy with 6-hydroxyquinine (chapter 3.4).  
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Figure 19. a) Possible conformational changes and isomerization processes affecting the excited 
state. b) Electron donor/acceptor moiety in bold. c) Deprotonation/protonation cascade possible in 
the excited state. 
Scytonemin was here investigated together with four different derivatives, two dimeric and 
two monomeric (Figure 20). We initially studied the absorption processes using an organic 
solvent of medium polarity, 2-methyltetrahydrofuran (Me-THF). Scytonemin and its 
corresponding methoxy derivative 16b are characterized by a broad absorption in the UVA-
region with an absorption maximum at 380nm (Figure 21). Compound 16a displayed similar 
behavior, but having a blue-shifted absorption maximum. The two monomeric derivatives, 
110a and 110b, displayed absorption spectra comparable to the dimeric counterparts. All 
compounds displayed a characteristic weak absorption far into the visible light region. The 
peculiar absorption is a weak HOMO-LUMO transition, as established by quantum 
mechanical calculations. 
N
ON
O
R
R
16a : R = H
16b : R = OMe
N
O
R
110a : R = H
110b : R = OMe  
Figure 20. Investigated derivatives of scytonemin. 
48 
 
 
Figure 21. a) Absorption spectra of scytonemin (―), derivative 16a (- -) and methoxy derivative 16b 
(∙-∙) in Me-THF. b) Absorption spectra of monomer 110a (- -) and 110b (∙-∙) in Me-THF. 
Next, the relaxation pathways were investigated. Fluorescence was measured after 
sequentially blocking the hypothetical deactivation routes outlined above. A change in 
fluorescence indicates whether or not a pathway is important for non-radiative relaxation. Any 
acid-base effects in the excited state should be suppressed in Me-THF, simplifying the 
hypothetical relaxation behavior. Further, methoxy derivative 16b cannot, independently of 
solvent effects, participate in a phenolic acid-base pathway. However, the absence of 
fluorescence for both scytonemin and its methoxy derivative in Me-THF indicated that other 
non-radiative processes were present beside acid-base effects. The impact of conformational 
changes was explored next using the monomeric derivatives, which cannot relax via rotation 
around the center bond (Figure 19). Unfortunately, fluorescence measurements of these 
molecules were difficult. Fluorescence was observed, but was not consistent with the 
absorption spectra. It also increased during measurements, indicating a decay of the parent 
compound into fluorescent substances. Relaxation due to center bond rotation could neither be 
confirmed nor disconfirmed from these measurements. Instead, low temperature studies were 
pursued. However, freezing methoxy derivative 16b in a solid Me-THF glass at 110K did not 
increase the fluorescence. In this state, no conformational changes can occur, indicating that 
there are other non-radiative pathways beside single-bond rotations and exocyclic double-
bond cis/trans-isomerization.  
The fluorescent studies were hampered by very fast photo-induced decay. For the unstable 
monomers, the buildup of fluorescent species was observed at room temperature. For the 
dimeric compound 16b, decay was observed during the low temperature studies. One or two 
emission spectra were enough to form new substances, which displayed a temperature 
dependent fluorescence. The observed photochemistry could be indicative of a long lived 
excited state, i.e. both the non-radiative relaxation processes and relaxation via fluorescence 
are slow.  
The photochemistry observed during the fluorescence measurements was studied further 
using a sun-lamp. Both scytonemin and the methoxy derivative 16b displayed a rapid loss of 
absorption when irradiated by the sun-lamp in Me-THF. The combination of light and oxygen 
is known to oxidize ethers into hydroperoxides via a radical reaction.152 Considering the anti- 
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Figure 22. Photo-decay of scytonemin in presence (―) and absence (- -) of air. a) Measured in Me-
THF before and after 1h of sun-lamp irradiation. b) Measured in EtOAc before and after 3h of sun-
lamp irradiation. 
oxidative activity of scytonemin, the decay could result from a radical reaction with the 
solvent. To exclude specific Me-THF effects, the experiment was repeated in ethyl acetate 
(EtOAc). Scytonemin was indeed more stable in EtOAc, albeit still displaying decay. To 
further investigate oxidative effects on the degradation, scytonemin was irradiated in the 
absence of oxygen. However, neither oxygen free Me-THF nor oxygen free EtOAc had any 
significant effect on the decomposition of scytonemin, thus eliminating the involvement of 
any oxygen associated reactions (Figure 22).  
To further monitor and characterize the decay of scytonemin, HPLC coupled mass-
spectrometry was used. Experiments were run in EtOAc and in 95% aqueous EtOH. 
Scytonemin displayed a linear decay in both solvents (Figure 23). No single degradation 
product could be observed and scytonemin likely decompose into a plethora of different 
substances, each one only present in minute quantities. Interestingly, the aqueous ethanol 
system had a stabilizing effect on scytonemin, resulting in a two and a half time slower decay 
compared to EtOAc. The relative stability of scytonemin can be concluded to be Me-THF < 
EtOAc < EtOH. 
 
Figure 23. Sun-lamp induced photo-decay of scytonemin in EtOAc (―) and 95% aqueous EtOH (- -) 
analyzed by HPLC. 
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To attain a qualitative apprehension of the photo-induced decay of scytonemin, it was 
compared with two commercially available UV-screening agents; bemotrizinol and 
avobenzone (Figure 24). The first is considered to be highly photo-stable, while the latter 
display the opposite behavior.153 The absorbance of bemotrizinol was constant over an 
irradiation period of six hours while avobenzone displayed a small decay. However, the 
absorbance of scytonemin was almost completely eradicated during the same period (Figure 
24). Consequently, scytonemin displayed a decay rate several magnitudes greater than that of 
the unstable sunscreen avobenzone. 
 
Figure 24.a) Photo-decay of scytonemin (―), avobenzone (- -) and bemotrizinol (∙∙) in EtOAc at 0h, 
3h and 6h of sun-lamp irradiation. b) Structures of avobenzone (13) and bemotrizinol (117). 
To conclude, scytonemin and its methoxy derivative 16b do not show any fluorescence in 
organic solvents. Further, derivative 16b displayed an absence of fluorescence even in a 
conformationally frozen state. Under these conditions, excited state relaxations due to 
isomerizations or conformational changes are blocked, as well as excited state acid-base 
reactions. Regardless of the deactivation pathway, scytonemin and the derivative 16b were 
found to be highly photo-unstable in organic solvents, possibly indicating a long lived excited 
state. Dissolution of scytonemin in aqueous ethanol had a stabilizing effect, a phenomenon 
which could have a number of different explanations. The highly polar solvent could stabilize 
an excited charge separated species and thereby introducing a new relaxation pathway. 
Another possibility is an excited state acid-base reaction. Phenol proton disassociations 
demonstrate a strong dependence on water, and the aqueous conditions could open up that 
pathway.118 Unfortunately, we were unable to test methoxy derivative 16b in EtOH, which 
could further strengthen or rule out a proton dissociative pathway. Nonetheless, the photo-
stability of scytonemin seems to be very dependent on its surroundings. 
In cyanobacteria, scytonemin is surrounded by a viscous matrix consisting of glycan 
polysaccharides and proteins.9, 10 The environment offers plenty hydrogen bonding 
opportunities as well as more specific interactions. For instance, the scytonemin producing 
specie Nostoc Commune accumulates the water stress protein WspA in its extracellular 
matrix. Scytonemin and WspA have been demonstrated to non-covalently interact with one 
another, possibly indicating a synergistic effect in the bacteria.10 Considering the 
environmental susceptibility described by us, together with the specific in vivo environment of 
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scytonemin, the reported in vivo photo-stability may be highly dependent on interactions with 
components of the extracellular matrix, explicit interactions which are not available upon 
dissolution in organic solvents.  
The results presented here questions the proposed application of scytonemin as a sunscreen. 
Scytonemin has likely been "developed", i.e. evolutionary selected, to function specifically in 
a cyanobacterial environment. If it is ever to be used efficiently as sunscreen for personalized 
use, the sunscreen formulation (matrix) may need to mimic the cyanobacterial extra cellular 
matrix. This does not necessarily implicate using exactly the same mixture of polysaccharides 
and proteins, but rather that the formulation needs to mimic the stabilizing effect displayed by 
these components. 
4.6 Biological studies of the 3-alkenyl-cyclopenta[b]indole skeleton (Paper 
III) 
Scytonemin has in several studies demonstrated an inhibiting effect on cancer cell growth. Its 
ability to inhibit kinases via a mixed competitive/non competitive mechanism has also been 
established.37 Despite recent breakthroughs in the treatment of advanced melanoma by 
targeting the kinase BRAF, tumor adaptation and adverse side effects are still problematic.58, 
60 Developing new scaffolds targeting melanoma-relevant kinases has been proposed as a 
strategy for improving the treatment. Against this background, we investigated the possibility 
of developing anti-melanoma relevant kinase inhibitors based on the scytonemin skeleton. We 
initially screened scytonemin, nostodione A and the reduced scytonemin monomer 70e 
(Figure 25) against 20 cancer related kinases. Peculiarly, we were not able to repeat the 
reported kinase inhibitory effect of scytonemin against polo-like kinase 1 (PLK1).37 
Scytonemin has a reported IC50 of 2 μM, but no effect was observed even at the screening 
concentration of 10 μM. While the reported PLK1 assay used a reaction medium containing 
4% DMSO, the assay used in our case only contained 2% DMSO. The observed difference 
may simply be due to the poor solubility of scytonemin. The kinases Aurora A and IKKβ 
were however inhibited by scytonemin, indicating that it was at least in part solubilized. 
Continuing from the rather discouraging results concerning scytonemin, we were pleased with 
a number of exciting observations connected to the monomer 70e. It displayed inhibitory 
properties against the kinases Aurora A, Aurora B, BRAF V600E and IRAK4. The Aurora 
kinases are intimately involved in cell mitosis, and frequently over expressed in cancers, e.g. 
melanoma. The close oncogenic relation has initiated an intense research around Aurora 
kinase inhibitors.154 BRAF V600E is one of the most promising targets for melanoma and has 
been previously discussed (see chapter 1.4). IRAK4 is primarily related to inflammatory 
signaling pathways, but is also involved in cell survival and differentiation. In melanoma, 
inhibition of IRAK4 has been demonstrated to amplify the therapeutic effects of other anti-
cancer agents.155 
Encouraged by the results, we initiated cell studies to determine the compatibility of 
compound 70e with biological systems. Detailed results are presented in paper III. In 
summary, the monomer displayed low toxicity with an IC50 of 20 µM. Very strong interaction 
with other cellular targets could thereby be ruled out. Further, flow cytometry revealed an 
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apoptotic mechanism to be responsible for the cellular growth inhibition, which agrees with 
inhibition of Aurora A, Aurora B and BRAF. At last, the fluorescent properties of compound 
70e (see chapter 4.2.1) were used to determine its cellular localization. The inhibitor was cell 
permeable and localized both in the cytosol and nucleus, concurring with the cellular 
localization of BRAF and IRAK4 (cytosol) as well as Aurora A and B (nucleus). 
The initial cell studies were regarded as promising and a small structure-activity examination 
was pursued. Totally 14 derivatives with structural differentiation at the exocyclic double 
bond were assayed against Aurora A, Aurora B, BRAF and IRAK4 (Figure 25). A few 
interesting structure-activity observations will be highlighted here, please see paper III for the 
complete results. Small structural changes had a major impact on the kinase inhibition of 
BRAF and IRAK4 while inhibition of the Aurora kinases was more robust throughout the 
series. The observation is illustrated well by derivative 70b. The methoxy derivative retains 
its inhibitory effects against Aurora A and B, while it is totally ineffective against BRAF. 
Interestingly, not only is its inhibitory effect against IRAK4 abolished, but it does 
paradoxically activate the enzyme. Derivative 70b likely binds to an allosteric site of IRAK4, 
where it induce a conformational change that further activates the kinase.  
Concerning inhibition of BRAF V600E, derivative 70g, having a hydroxyl group in the meta-
position proved to be equally potent to the para-compound 70e. Acetamide derivative 70h, 
having a hydrogen-bond donor in the same position as parent monomer 70e, displayed a 
comparably poor inhibition of BRAF. The acetamide group modifies the ligand-kinase 
interactions primarily through the translocation of the hydrogen-bond acceptor and through 
the sheer bulk of the substituent. Pyridine 70i, lacking a hydrogen-bond donor but having a 
hydrogen-bond acceptor demonstrated inhibition of BRAF, but less so than parent compound 
70e. The more bulky hydrogen-bond accepting molecules 70c and 70j displayed weak 
inhibition. Finally, the fluorinated derivative 70k, unable to form hydrogen-bonds, displayed 
no activity at all. Taken together, the inhibitors appear to benefit from hydrogen bond-
donating and accepting moieties on the aryl ring. The most potent compound 70e and 70g 
have both a donor and an acceptor, possibly indicating a synergistic effect. Further, the 
inhibitor seemed to be slightly flexible within the binding pocket of BRAF, as judged by the 
similar potencies of meta-substituted 70g and para-substituted 70e. The flexibility did 
however not render the compound insensitive to steric alterations of the hydrogen-bonding 
moieties, compare hydrogen-bond donating compound 70e and 70h as well as hydrogen bond 
accepting compounds 70c, 70i and 70j.  
Concerning IRAK4, meta-hydroxyl derivative 70g displayed a reduced potency compared to 
para-compound 70e. The pyridine 70i was on the other hand almost as active as 70e. Nitro 
compound 70c demonstrated a weak interaction while the bulky hydrogen-bond donating 
substance 70h and substances 70j and 70k were inactive. IRAK4 inhibition can be concluded 
to benefit from hydrogen bond accepting functional groups. Further, the position is important, 
compare 70e, 70g and 70i. Compounds of more lipophilic character did not inhibit any of the 
investigated kinases, indicating that water solubility likely is a limiting factor.  
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Figure 25. Selected kinase inhibitors from the structure-activity study. Kinase inhibition is reported 
as percent kinase activity remaining after treatment with 10μM compound at [ATP]≈Km. 
The promising cellular behavior of 70e and its inhibition of BRAF V600E, which is a 
clinically proven target for melanoma treatment, were the most interesting observations in this 
study. The combination of hydrogen-bond donor/acceptor moieties at the exocyclic alkenyl 
substituent proved vital for BRAF inhibition. Compounds of type 70l, 70m, 70n and 70o 
(Figure 26) could possibly exhibit synergistic effects which warrant future investigations. 
Introducing water solubilizing substituents in positions not affecting the binding can also 
improve performance and deserves future studies. It is also of interest to elucidate the mode of 
kinase interaction, determining whether it is of type I, II or III. 
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Figure 26. Potentially interesting BRAF V600E inhibitors. 
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5 Summary and conclusions 
This thesis touches upon several different subjects, ranging from natural product synthesis and 
statistical reaction optimization to spectroscopy and cell studies. Our work was initially 
concerned with the synthesis of scytonemin, nostodione A and related derivatives. The 
compounds were subsequently utilized in the development of kinase inhibitors and in the 
photophysicochemical characterization of scytonemin. The results therefore have implications 
on many different areas, and will hopefully be useful for both synthetic and medicinal 
chemists, as well as biologists working with the ecology of cyanobacteria. 
Our synthesis of scytonemin and nostodione A involved a key monomeric fragment (70), 
composed of a 3-alkenyl-cyclopenta[b]indole skeleton. The key fragment 70 was obtainable 
from the commercially available indole-3-acetic acid via either a seven or a six step synthetic 
pathway, both based on a palladium catalyzed annulation of the indole. The seven step 
synthetic route revolved around a cascade Heck-Suzuki reaction, which can be used to create 
compounds with structural diversity at the exocyclic alkenyl substituent. The reaction is a set 
of successive palladium catalyzed steps, which must occur in a specific order to secure a 
successful reaction outcome. Statistical experimental design (Design of Experiments, DoE) 
was used to optimize six variables likely to affect the multifaceted reaction. The palladium 
ligand was included as two latent variables obtained from principal component analysis 
(PCA), enabling it to be described in a quantitative, continuous manner. A very complex 
dependence on the ligand was found, which also was the most influential reaction variable. 
Using the obtained DoE-model, optimal reaction conditions were selected and utilized to 
synthesize 13 derivatives of 70. The study demonstrate how a complex reaction, in which the 
underlying mechanism is not completely understood, can be rationally optimized using DoE. 
We also demonstrate the significance of including ligand as a continuous variable using PCA. 
It was very influential and the complex ligand effect can likely not be described by any other 
method.  
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Both scytonemin and nostodione A could be readily synthesized from the monomeric 
structure 70. An oxidative coupling produced the dimeric structure of scytonemin, while a 
Yonemitsu reaction generated the dione moiety of nostodione A. We here demonstrate the 
versatility of our synthetic pathway, which is able to produce both scytonemin and nostodione 
A derivatives from a common intermediate 70. The synthesis of 70 is also diversity oriented, 
having the possibility to introduce different substituents at the exo-cyclic alkenyl group. With 
the ability to construct unnatural derivatives, structural properties of the natural products can 
be investigated and for instance placed into an evolutionary perspective. It can also be used to 
enhance specific properties, such as bioactivity. 
Contradictory to the reported in vivo photo-stability of scytonemin (i.e. whilst in the extra 
cellular matrix of the cyanobacteria), we have demonstrated that scytonemin is highly photo-
unstable in organic solvents. The instability displayed a solvent dependence according to: Me-
THF < EtOAc < EtOH, with scytonemin being most stable in EtOH. The presence of air did 
not influence the stability, indicating that an oxygen mediated effect was not responsible for 
the degradation. Further, a number of possible excited state deactivation pathways of 
scytonemin were investigated. The study was unfortunately unsuccessful as no fluorescence 
of the methoxy derivative 16b could be observed in Me-THF, even when blocking all 
envisioned relaxation pathways. However, considering the solvent effects, the deactivation 
pathways of scytonemin seem to be dependent on its surroundings. For instance, the 
stabilizing effect displayed by aqueous EtOH could point toward efficient relaxation via acid-
base reactions or internal charge transfers. Regardless of deactivation route, the observed 
solvent effect has implications on cyanobacterial ecology. The viscous extra cellular matrix of 
cyanobacteria consists of polysaccharides and proteins, offering a unique environment. The 
reported in vivo stability of scytonemin is likely due to specific matrix interactions, possibly 
providing an efficient excited state deactivation pathway that is not available upon dissolution 
in organic solvents. 
We found an in vitro inhibitory activity of 3-alkenyl-cyclopenta[b]indole-2-one monomer 70 
against four kinases, Aurora A, Aurora B, BRAF V600E and IRAK4, all relevant for 
combating melanoma. Inhibition of the kinase BRAF V600E has been clinically demonstrated 
to revert advanced melanoma, and finding new scaffolds for its inhibition is of particular 
interest. Totally 17 of our synthesized compounds, including scytonemin and nostodione A, 
were assayed against the kinases in a small structure-activity study. A number of interesting 
traits, which can be used in further inhibitor developments, were found. One of the more 
promising compounds, phenolic compound 70e, was studied in a cellular context using 
peripheral blood mononuclear cells (PBMC). It induced cell apoptosis, agreeing with 
inhibition of investigated kinases. The cytotoxicity was low, indicative of only weak off-
target interactions. It was further cell permeable and distributed both in the cytosol and 
nucleus, coinciding with the cellular location of the investigated kinases.  
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6 Future studies 
The developed synthetic pathways can in future studies be utilized to synthesize tailored 
compounds of interest. The routes can also be elaborated to fulfill future need of 
complementary derivatization according to the following suggestions: 
• Enolate chemistry can be utilized to introduce substituents at C-1 of 3-alkenyl-
cycopenta[b]indole-2-one scaffold 70. Attractive examples of enolate chemistries 
include condensations (e.g. aldol), transition metal catalyzed cross-couplings and 
oxidative hetero-couplings.  
• Substitution on the indole nitrogen.  
• Using different alkynes in the nucleophilic substitution of the Weinreb amide 76 to 
produce compounds that via the cascade Heck-Suzuki reaction generate additional 
diversity at the exocyclic double bond. 
The photo-instability of scytonemin was not anticipated and should be investigated further, 
with the final goal of elucidating the environmental stabilizing/destabilizing mechanism. For 
this purpose, the following solvent based studies are proposed: 
• Study scytonemin in non-protic solvents of various polarity. It will give insight to 
effects not involving hydrogen transfer reactions and hydrogen bonding.  
• Study scytonemin in acetone, DMF or DMSO solutions with increasingly higher water 
content. The study can be indicative of stabilizing/destabilizing effects specifically 
involving hydrogens. 
• Study different relevant additives, such as polysaccharides and proteins. The study can 
be thought of as a simulation of the cyanobacterial extracellular matrix. It may give 
valuable insight into the photo-stability. 
Inhibition of BRAF V600E and the favorable cellular behavior of 3-(4-hydroxybenzylidene)-
cyclopenta[b]indole-2-one monomer 70e were the most interesting results from the anti-
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melanoma study. The 3-alkenyl substituent of the scaffold 70 has been investigated and 
suggestions of better performing substituents in this position have been presented. To improve 
the scaffold further, future studies should focus on elucidating the binding mode by: 
• Using a kinase inhibition assay differentiating between type I and type II inhibitors. 
• Co-crystallization of BRAF V600E and 70e 
• Using computational ligand-protein docking simulations. 
With an established mode of binding, rational design can be used to: 
• Introduce water solubilizing substituents in a position which will not affect the 
inhibition. The inhibitors displayed water solubility as a limiting factor, and the 
proposed modification will likely be beneficial. 
• Strengthen the kinase-protein binding by introducing new substituents which actively 
interact with the protein. 
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9 Appendix for unpublished experimental procedures 
General procedures: All reactions were carried out under argon atmosphere with dry 
solvents in oven dried glassware, unless otherwise noted. Reagents and solvents were bought 
from commercial vendors and used as received, unless otherwise stated. Dry oxygen free THF 
was obtained through distillation over sodium under nitrogen gas. Dry oxygen free Et3N was 
obtained through distillation over calcium hydride under nitrogen gas. DMF was purchased in 
anhydrous form and used without further purification. For the transition metal catalyzed 
reactions, oxygen free DMF and acetone were obtained by bubbling argon through the 
solvents for 30 min. Reactions were monitored by thin-layer chromatography (TLC) carried 
out on Merck silica gel plates (60F-254) using UV light as visualizing agent. NMR spectra were 
recorded on samples in either deuterated chloroform (CDCl3) or acetone (acetone-d6) on 
either a JEOL Eclipse 400 MHz (101 MHz for 13C) or an Agilent 400 MHz (101 MHz for 
13C) instrument. Residual undeuterated solvent was used as internal reference: chloroform 
(1H: δ = 7.26 ppm, 13C: δ = 77.0 ppm) and acetone (1H: δ = 2.05 ppm, 13C: δ = 29.8 ppm). The 
following abbreviations, or a combination thereof, were used to characterize the multiplicities: 
s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. Melting points (mp) 
were recorded on a Mettler FP 90/82 melting point apparatus and are uncorrected. HRMS 
analysis were performed on either a Waters Micromass Q-Tof micro instrument or a QSTAR 
XL using positive electrospray ionization and a tandem quadropole time-of-flight mass 
analyzer (ESI+ qTOF). Preparative HPLC was performed using a Gilson pump model 305, a 
Gilson UV/VIS detector model 119 and a Zorbax Semi-Preparative column (250 mm × 9.4 
mm, 5 µm particles, Agilent Technologies) by monitoring the compounds at 380 nm. 
Synthesis of ketone 89a. A solution of n-BuLi in toluene (1.95 ml, 1.6 M, 3.1 mmol) was 
added dropwise to a stirred solution of phenyl acetylene (0.45 ml, 4.1 mmol) in THF (5 ml, 
0.8 M) at -78°C. After being stirred for 1 hour at -78°C, the reaction mixture was warmed to 
rt, stirred for additional 15 minutes and then cooled to -78°C. The solution of lithium 
phenylacetylide was added to a solution of Weinreb amide 76 (0.42 g, 1.2 mmol) in THF (20 
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ml, 0.06 M) at -78°C via a transfer cannula. The yellow reaction mixture was stirred at -78°C 
for 30 minutes, then allowed to warm to rt and stirred for an additional hour. The reaction was 
cooled to -78°C and quenched with NaHSO4 (30 ml, sat. aq.), then extracted with EtOAc (3 × 
20 ml), washed with brine, dried over Na2SO4 and concentrated under reduced pressure. The 
crude product was purified by column chromatography (Petroleum ether/EtOAc 4:1) to give 
89a (0.35 g, 75 %) as pale yellow crystals; mp 137 - 139°C; δH(400 MHz, Chloroform-d) 4.00 
(s, 2H), 7.10 – 7.18 (m, 2H), 7.28 - 7.40 (M, 6H), 7.56 - 7.58 (d, J = 7.68 Hz, 1H), 8.18 (br s, 
1H); δC(101 MHz, chloroform-d) 184.5, 138.9, 133.3, 130.8, 128.6, 127.8, 122.8, 120.5, 
120.0, 118.4, 114.4, 110.6, 92.5, 88.0, 80.7, 43.8. 
Synthesis of alcohol 90a. A solution of n-BuLi in hexanes (2.5 ml, 2.5 M, 6.3 mmol) was 
added dropwise to a solution of phenylacetylene (0.72 ml, 6.6 mmol) in THF (13 ml, 0.5 M) 
at -78 °C. The reaction mixture was stirred for 25 min at -78 °C followed by 20 min at room 
temperature. The lithium phenylacetylide solution was added dropwise to a solution of 
Weinreb amide 76 (0.56 g, 1.6 mmol) in THF (65 ml, 0.025 M) at -78 °C. The reaction 
mixture was warmed to room temperature and stirred for 2 h, recooled to -78 °C and 
quenched with NaHSO4 (50 ml, sat. aq./H2O 1:1). The mixture was warmed to room 
temperature and the formed layers were separated. The aqueous layer was extracted with 
EtOAc (3 × 40 ml) and the combined organic phases were washed with brine (40 ml), dried 
over Na2SO4, filtered, and concentrated under reduced pressure until 20 ml remained. The 
solution was diluted with EtOH (30 ml), concentrated under reduced pressure to 20 ml, 
diluted with EtOH (30 ml) and finally concentrated to 20 ml again. To the solution under air 
atmosphere was added EtOH (45 ml) and NaBH4 (72 mg, 1.9 mmol). The resulting solution 
was stirred for 1 h, quenched with NH4Cl (25 ml, sat. aq.) and diluted with brine (25 ml). The 
mixture was extracted with DCM (2 × 40 ml) and the combined extracts were dried over 
Na2SO4, filtered and concentrated onto silica gel (7 g). The silica bound crude product was 
purified by column chromatography (DCM) to afford 90a (0.44 g, 70% over 2 steps) as white 
crystals; Rf = 0.3 (DCM); δH(400 MHz, Chloroform-d) 8.19 (br s, 1H), 7.72 – 7.67 (m, 1H), 
7.39 – 7.35 (m, 2H), 7.32 – 7.26 (m, 4H), 7.18 – 7.08 (m, 2H), 4.93 (apparent q, J = 6.3 Hz, 
1H), 3.29 (dd, J = 14.2, 6.3 Hz, 1H), 3.25 (dd, J = 14.1, 6.6 Hz, 1H), 2.14 (d, J = 5.7 Hz, 1H). 
Synthesis of alcohol 90b. A solution of n-BuLi in hexanes (2.8 ml, 2.5 M, 7.0 mmol) was 
added dropwise to a solution of 4-ethynylanisole (0.95 ml, 7.3 mmol) in THF (14 ml, 0.5 M) 
at -78 °C. The reaction mixture was stirred for 30 min at -78 °C followed by 15 min at room 
temperature. The lithium phenylacetylide solution was added dropwise to a solution of 
Weinreb amide 76 (1.1 g, 3.2 mmol) in THF (125 ml, 0.025 M) at -78 °C. The reaction 
mixture was warmed to room temperature and stirred for 2.5 h, recooled to -78 °C and 
quenched with NaHSO4 (40 ml, sat. aq./H2O 1:1). The mixture was warmed to room 
temperature and the formed layers were separated. The aqueous layer was extracted with 
EtOAc (3 × 50 ml) and the combined organic layers were washed with H2O (50 ml) and brine 
(50 ml), dried over Na2SO4, filtered, and concentrated under reduced pressure until 10 ml 
remained. The solution was diluted with EtOH (50 ml) and concentrated under reduced 
pressure to 30 ml. To the solution under air atmosphere was added EtOH (100 ml) and NaBH4 
(129 mg, 3.4 mmol). The resulting solution was stirred for 1 h and 20 min, quenched with 
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NH4Cl (40 ml, sat. aq.) and diluted with brine (50 ml). The mixture was extracted with DCM 
(2 × 60 ml) and the combined extracts were dried over Na2SO4, filtered and concentrated 
under reduced pressure to an oily residue. The crude product was purified by column 
chromatography (DCM) to yield 90b (1.12 g, 84% over 2 steps) as slightly off-white crystals; 
Rf = 0.15 (DCM); mp = 47 – 49°C; δH(400 MHz, Chloroform-d) 8.11 (br s, 1H), 7.69 (ddt, J 
= 7.6, 1.6, 0.8 Hz, 1H), 7.34 – 7.28 (m, 3H), 7.17 – 7.12 (m, 1H), 7.12 – 7.08 (m, 1H), 6.84 – 
6.78 (m, 2H), 4.91 (apparent q, J = 6.3 Hz, 1H), 3.27 (dd, J = 14.1, 6.3 Hz, 1H), 3.23 (dd, J = 
14.1, 6.5 Hz), 2.02 (d, J = 5.9 Hz, 1H); δC(101 MHz, Chloroform-d) 159.6, 138.8, 133.2, 
128.0, 122.4, 120.0, 118.6, 117.2, 114.7, 113.8, 110.3, 88.4, 85.3, 79.8, 63.3, 55.3, 35.6; 
HRMS (ESI+ qTOF) calcd for C19H17INO2 [M + H] 418.0304, found 418.0312. 
Synthesis of cyclopenta[b]indole-2-ol 92a. To a stirred solution of alcohol 90a (0.41 mg, 
0.11 mmol) and PdCl2(PPh3)2 (16 mg, 0.022 mmol) in DMF (1.1 ml, 0.1 M) was added Et3N 
(50 μl, 0.34 mmol) and HCOOH (8 μl, 0.21 mmol). The solution was heated to 60°C, stirred 
for 6 h and then cooled to rt. The mixture was run through a short pad of silica to remove the 
catalyst. The silica pad was eluted with EtOAc (10 ml) and the obtained solution was 
concentrated under reduced pressure and left under a stream of N2 for a night to remove the 
DMF. Dissolution of the residue in deuterated acetone (0.7 ml) was followed by the addition 
of 1,3,4-trimethoxybenzene (1.61 mg, 9.6 μmol) and hexamethylbenzene (1.30 mg, 8.0 μmol) 
as internal standards. 1H-NMR was run with a relaxation delay of 5 s. The yield was 
calculated by comparing product peaks at δ 6.88, 5.54 and 3.40 with those of 1,3,4-
trimethoxybenzene δ 3.75 and hexamethylbenzene δ 2.17. The same method was used for all 
hydride sources. When the hydride source was a solid, it was added together with the 
substrate and catalyst. 
Synthesis of cyclopenta[b]indole-2-ol 92b. To a stirred solution of alcohol 90b (0.68 g, 1.6 
mmol), Pd(OAc)2 (72 mg, 0.32 mmol) and PPh3 (0.17 g, 0.65 mmol) in DMF (32 ml, 0.05 M) 
was added Et3N (0.70 ml, 4.8 mmol) and HCOOH (0.12 ml, 3.2 mmol). The solution was 
heated to 60°C, stirred for 6 h and then cooled to rt. The solution was run through a short pad 
of silica to remove the catalyst. The silica pad was eluted with EtOAc (100 ml) and the 
obtained solution was concentrated under reduced pressure at 80°C to remove most of the 
DMF. The oily crude product was purified by column chromatography (DCM) to give 
product 92b in a mixture with DMF. The mixture was dissolved in DCM and washed with 
H2O (5 × 15 ml), dried over Na2SO4, filtered and concentrated yield pure 92b (0.39 g, 85 %) 
as tan crystals; Rf = 0.15 (DCM); mp = 187 – 190°C; δH(400 MHz, Acetone-d6) 10.25 (br s, 
1H), 7.73 (AA' part of a AA'XX' system, 2H), 7.43 (ddt, J = 7.8, 1.4, 0.7 Hz, 1H), 7.35 (dt, J 
= 8.1, 1.0 Hz, 1H), 7.09 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 7.01 (ddd, J = 7.8, 7.1, 1.1 Hz, 1H), 
6.93 (XX' part of AA'XX' system, 2H), 6.72 (d, J = 1.4 Hz, 1H), 5.49 (ddt, J = 7.8, 6.1, 1.2 
Hz, 1H), 4.41 (d, J = 8.0 Hz, 1H), 3.82 (s, 3H), 3.39 (dd, J = 15.8, 6.1 Hz, 1H), 2.87 (dd, J = 
15.8, 1.1 Hz, 1H); δC(101 MHz, Acetone-d6) δ 159.6, 144.2, 143.2, 136.5, 131.99, 130.98, 
126.0, 122.8, 122.5, 120.24, 120.23, 119.7, 114.6, 112.5, 76.9, 55.5, 36.7; HRMS (ESI+ 
qTOF) calcd for C19H18NO2 [M + H] 292.1338, found 292.1336. 
Synthesis of reduced scytonemin monomer 70b via Oppenaur type reaction. A solution 
of alcohol 92b (0.39 g, 1.4 mmol) and Shvo catalyst (101) (27 mg, 0.026 mmol) in acetone 
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was refluxed for 24 h. The solution was cooled to rt and run through a plug of silica. The plug 
was further eluted with EtOAc (150 ml) and the combined solvent was concentrated onto 
silica (4 g). The silica bound crude product was purified by column chromatography 
(hexanes/DCM 1:4) to yield product 70b (0.33 g, 85 %) as a yellow crystalline mixture of 
E/Z-stereoisomers. The isomers equilibrated in solution until E/Z 98:2 was reached. 
Spectroscopic data agreed with our previous report (see paper I). 
Synthesis of ketone 102. A solution of n-BuLi in hexanes (3.2 ml, 2.5 M, 8.0 mmol) was 
added to a solution of phenylacetylene (1.0 ml, 9.1 mmol) in THF (11 ml, 0.8 M) at -78°C. 
The reaction mixture was stirred for 1 h at -78°C, then warmed to room temperature and 
stirred for additional 15 min. The reaction mixture was recooled to -78°C and transferred to a 
solution of Weinreb amide 75 (0.50 g, 2.3 mmol) in THF (32 ml, 0.07 M) at -78°C. The 
reaction mixture was stirred for 30 min, then warmed to room temperature and stirred for 
additional 75 min. The reaction was cooled again to -78°C and quenched by the addition of 
NaHSO4 (50 ml, sat. aq.). After warming to rt, the mixture was extracted with EtOAc (3 × 40 
ml) and the combined organic layers were washed with brine (80 ml), dried over MgSO4 and 
concentrated under reduced pressure. The crude product was purified by column 
chromatography (Petroleum ether/EtOAc 1:1) to obtain 102 (0.48 g, 80%) as pale yellow 
crystals; δH(400 MHz, Chloroform-d) 8.16 (br s, 1H), 7.68 (ddt, J = 7.8, 1.4, 0.8 Hz, 1H), 7.44 
– 7.29 (m, 6H), 7.26 – 7.21 (m, 2H), 7.17 (ddd, J = 7.7, 7.1, 1.1 Hz, 1H), 4.09 (d, J = 0.8 Hz, 
2H). 
Synthesis of alcohol 103. To a stirred solution of ketone 102 (0.28 g, 1.1 mmol) in ethanol 
(107 ml, 0.01 M) under air atmosphere was added NaBH4 (40 mg, 1.1 mmol). The reaction 
mixture was stirred for 2 h at 0°C and then quenched with HCl (50 ml, 1 M, aq.). Brine (200 
ml) was added and the mixture was extracted with EtOAc (50 ml) and DCM (50 ml). The 
combined organic layers were dried over Na2SO4, filtered and concentrated under reduced 
pressure. The crude product was purified by column chromatography (DCM) to yield 103 (97 
mg, 34%) as brown crystals; δH(400 MHz, Chloroform-d) 8.13 (br s, 1H), 7.75 (ddt, J = 7.9, 
1.4, 0.8 Hz, 1H), 7.42 – 7.36 (m, 3H), 7.34 – 7.28 (m, 3H), 7.23 (ddd, J = 8.3, 7.1, 1.2 Hz, 
1H), 7.19 – 7.14 (m, 2H), 4.90 (t, J = 5.4 Hz, 1H), 3.35 (ddd, J = 14.4, 5.5, 0.8 Hz, 1H), 3.28 
(ddd, J = 14.4, 6.6, 0.7 Hz, 1H), 2.25 (br s, 1H). 
Synthesis of carbazole 105. To a stirred solution of gold catalyst 107 (18 mg, 0.02 mmol) in 
CH2Cl2 (5 ml) was added a solution of ketone 102 (52 mg, 0.20 mmol) in CH2Cl2 (1 ml). The 
reaction mixture was stirred for 4 h at rt and then run through a short silica plug, eluted with 
EtOAc. The solution was concentrated under reduced pressure and the obtained crude product 
was purified by column chromatography (DCM) to yield 105 (35 mg, 68%) as brown crystals; 
δH(400 MHz, Chloroform-d) 8.14 (br s, 1H), 8.02 (dq, J = 7.9, 0.8 Hz, 1H), 7.70 – 7.65 (m, 
2H), 7.57 – 7.52 (m, 2H), 7.51 (dd, J = 2.4, 0.6 Hz, 1H), 7.47 – 7.36 (m, 3H), 7.21 (ddd, J = 
8.0, 6.3, 1.8 Hz, 1H), 7.02 (d, J = 2.4 Hz, 1H), 4.82 (br s, 1H). 
Synthesis of carbazole 109. To a stirred solution of gold catalyst 108 (6 mg, 0.02 mmol) in 
CH2Cl2 (5 ml) was added a solution of alcohol 103 (49 mg, 0.19 mmol) in CH2Cl2 (1 ml). The 
reaction mixture was stirred for 4 h at rt and then run through a short silica plug, eluted with 
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EtOAc. The solution was concentrated under reduced pressure and the obtained crude product 
was purified by column chromatography (petroleum ether/DCM 3:2) to yield 109 (41 mg, 
90%) as brown crystals; δH(400 MHz, Chloroform-d) 8.32 (s, 1H), 8.13 (dq, J = 7.8, 0.9 Hz, 
1H), 8.10 (ddd, J = 7.8, 1.2, 0.7 Hz, 1H), 7.74 – 7.69 (m, 2H), 7.61 – 7.55 (m, 2H), 7.49 – 
7.40 (m, 4H), 7.34 (t, J = 7.6 Hz, 1H), 7.30 – 7.24 (m, 1H). 
Synthesis of monomer 110d. To reduced monomer 70d (60 mg, 0.14 mmol) in THF/H2O (28 
ml, 0.005 M) at 0°C under air atmosphere was added DDQ (73 mg, 0.32 mmol). The solution 
was stirred for 30 seconds, then diluted with EtOAc (50 ml). The solution was washed with 
NaHCO3 (4 × 5 ml, sat. aq.) to remove DDQ-adducts. The organic layer was further washed 
with brine (10 ml), dried over Na2SO4, filtered and concentrated onto SiO2 (1.5 g). The silica 
bound crude product was purified by column chromatography (petroleum ether/EtOAc 95:5) 
to yield monomer 110d (13 mg, 21%) as a red oil; Rf = 0.55 (hexane/EtOAc 3:1); δH(400 
MHz, Chloroform-d) 8.53 (AA' part of AA'XX' system, 2H), 7.69 (dt, J = 7.4, 1.0 Hz, 1H), 
7.65 (dq, J = 7.8, 0.8 Hz, 1H), 7.53 – 7.48 (m, 2H), 7.22 (tt, J = 7.5, 0.9 Hz, 1H), 7.01 (XX' 
part of AA'XX' system, 2H), 6.86 (s, 1H), 1.36 – 1.25 (m, 3H), 1.13 (d, J = 7.4 Hz, 18H); 
δC(101 MHz, Chloroform-d) 197.3, 174.7, 162.7, 160.2, 159.6, 137.5, 135.2, 134.1, 127.3, 
127.1, 126.3, 125.9, 124.2, 121.9, 120.4, 119.9, 17.9, 12.7; HRMS (ESI+ qTOF) calcd for 
C27H32NO2Si [M + 1] 430.2202, found 430.2229. 
Synthesis of dimer 113d. LDA was freshly prepared by the addition of n-BuLi in hexanes 
(0.5 ml, 2.5 M, 1.24 mmol) to a stirred solution of diisopropylamine (0.19 ml, 1.4 mmol) in 
THF (11 ml, 0.12M) at -78°C. The solution was stirred for 30 min followed by a dropwise 
addition of reduced monomer 70d (0.27 g, 0.62 mmol) in THF (11 ml, 0.06 M). The resulting 
enolate solution was stirred for 5 min and a solution of FeCl3 (0.22 g, 1.36 mmol) in DMF 
(6.2 ml, 0.2 M) was added. The mixture was allowed to warm to rt, stirred for 23 h and 
quenched by the addition of HCl (20 ml, 0.5 M, aq.). The resulting phases were separated and 
the aqueous layer was extracted with EtOAc (3 × 15 ml). The combined organic layers were 
washed with H2O (3 × 12 ml) and brine (10 ml), dried over Na2SO4, filtered and concentrated 
to a black oily residue. The crude product was purified by column chromatography 
(hexane/DCM 95:5 → 1:1) to yield 113d (0.14 g, 52%) as an oily mixture of 
diastereoisomers; Rf = 0.2 (Hexane/DCM 1:1); HRMS (ESI+ qTOF) calcd for C54H65N2O4Si2 
[M + 1] 861.4483, found 861.4483; No NMR is reported due to the mixture of 
diastereoisomers, which produce a complex NMR-spectrum. 
Synthesis of dimer 113f. LDA was freshly prepared by the addition of n-BuLi in hexanes 
(0.16 ml, 2.5 M, 0.39 mmol) to a stirred solution of diisopropylamine (60 μl, 0.40 mmol) in 
THF (2 ml, 0.2 M) at -78°C. The solution was stirred for 30 min followed by a dropwise 
addition of reduced monomer 70f (76 mg, 0.19 mmol) in THF (6 ml, 0.03 M). The resulting 
enolate solution was stirred for 5 min and a solution of FeCl3 (69 mg, 0.42 mmol) in DMF 
(2.2 ml, 0.2 M) was added. The mixture was allowed to warm to rt, stirred for 22 h and 
quenched by the addition of HCl (8 ml, 0.5 M, aq.). The resulting phases were separated and 
the aqueous layer was extracted with EtOAc (3 × 8 ml). The combined organic layers were 
washed with H2O (3 × 8 ml) and brine (8 ml), dried over Na2SO4, filtered and concentrated to 
a brown solid. The crude product was purified by column chromatography (hexane/DCM 1:1 
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→ 0:1) to yield 113f (45 mg, 59%) as an amorphous solid mixture of diastereoisomers; Rf = 
0.25 (DCM); HRMS (ESI+ qTOF) calcd for C52H41N2O6 [M + 1] 789.2965, found 789.3104; 
No NMR is reported due to the mixture of diastereoisomers, which produce a complex NMR-
spectrum. 
Synthesis of TIPS-protected scytonemin 16d. To a stirred solution of isomeric mixture 
113d (84 mg, 0.1 mmol) in THF (10 ml, 0.01 M) at 0°C under air atmosphere was added 
DDQ (47 mg, 0.21 mmol). The resulting dark solution was stirred for 15 min and then diluted 
with EtOAc (40 ml). The mixture was washed with NaHCO3 (4 × 10 ml, sat. aq.) to remove 
DDQ adducts and brine (10 ml), dried over Na2SO4, filtered and concentrated. The crude 
product was run through a pad of silica, eluted with DCM/EtOH (50 ml, 3:1), to further 
remove DDQ adducts. The solution was concentrated to yield rather pure 16d (77 mg, 92%) 
as a dark solid; δH(400 MHz, Chloroform-d) 8.60 (AA' part of AA'XX' system, 2H), 7.68 (s, 
1H), 7.63 (dt, J = 7.7, 0.8 Hz, 1H), 7.49 (td, J = 7.6, 1.2 Hz, 1H), 7.44 (ddd, J = 7.5, 1.3, 0.6 
Hz, 1H), 7.15 (td, J = 7.5, 1.0 Hz, 1H), 7.04 (XX' part of AA'XX' system, 2H), 1.38 – 1.24 
(m, 3H), 1.14 (d, J = 7.3 Hz, 18H). 
Synthesis of scytonemin (1) from 16d. To a stirred solution of 16d (58 mg, 0.067 mmol) in 
DMF/H2O (6.7 ml, 20:1, 0.01 M) at 0°C under air atmosphere was added solid KOAc (27 mg, 
0.27 mmol). The solution was warmed to rt, stirred for 15 min and then diluted with EtOAc 
(60 ml). The solution was washed with H2O (4 × 20 ml) and brine (20 ml), dried over 
Na2SO4, filtered and concentrated to a black solid. The solid was dissolved in THF (2 ml) and 
precipitated by the dropwise addition of hexane (50 ml) over 5 h. The mixture was cooled to -
20°C and after 14h, the motherliquid was removed using a pipette. The precipitate was 
dissolved in THF (16 ml), diluted with H2O/MeCN (18 ml, 4:1) and divided into four equal 
portions. Each of the four solutions was purified on a column packed with C18-silica (0.5 g, 
pre-equilibrated with 3 ml MeOH and 3 ml H2O/MeCN 4:1). The columns were eluted with 
additional H2O/MeCN (4 ml, 4:1) and THF (5 ml) each. One fraction (A) was eluted with 
H2O/MeCN and a second (B) with THF. The first fraction (A) was concentrated under 
reduced pressure to remove MeCN, diluted with EtOAc (100 ml) and brine (20 ml). The 
layers were separated and the aqueous phase was extracted with EtOAc (50 ml). The 
combined organic layers were washed with H2O (3 × 15 ml) and brine (15 ml), dried over 
Na2SO4, filtered and concentrated under reduced pressure to yield scytonemin (20 mg) as a 
green/brown solid. The second fraction (B) was concentrated under reduced pressure to 
remove THF, diluted with EtOAc (60 ml), washed with H2O (3 × 10 ml) and brine (10 ml), 
dried over Na2SO4, filtered and concentrated to a dark solid. The solid was dissolved in 
acetone (5 ml) and purified by preperative HPLC. Aliquots of 0.2 ml were injected and eluted 
with H2O/MeCN (3:7) at a flow rate of 10 ml/min. The obtained solution was concentrated 
under reduced pressure to remove MeCN and the resulting aqueous solution was extracted 
with EtOAc (3 × 50 ml). The combined extracts were washed with brine (50 ml), dried over 
Na2SO4, filtered and concentrated to yield scytonemin (6 mg) as a green/brown solid. Totally 
26 mg, 71 %, scytonemin was obtained; Spectroscopic data agreed with our previous reports. 
Synthesis of scytonemin (1) from 113f. BBr3 in DCM (0.13 ml, 1 M, 0.13 mmol) was added 
to a stirred solution of dimer 113f (26 mg, 0.03 mmol) in DCM (3.3 ml, 0.01 M) at -78°C. 
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The dark solution was stirred for 50 min and then quenched with H2O (3.3 ml). After 
warming the mixture to rt, EtOAc (12 ml) was added and the formed layers were separated. 
The aqueous layer was extracted with EtOAc (2 × 7 ml) and the combined organic phases 
were washed with brine (7 ml), dried over Na2SO4, filtered and concentrated under reduced 
pressure to a red/brown solid. The crude product was dissolved in THF (1.65 ml) under air 
atmosphere and cooled to -78°C. DDQ (16 mg, 0.07 mmol) was added and the resulting 
mixture was stirred for 20 min followed by concentration under reduced pressure. The black 
solid was dissolved in acetone (2 ml) and precipitated by the addition of hexane (10 ml). The 
solid precipitate was redisolved in acetone (5 ml) and purified by preparative HPLC. Aliquots 
of 0.1 ml were injected and eluted with H2O/MeCN (3:7) at a flow rate of 7 ml/min. The 
obtained solution was concentrated under reduced pressure to remove MeCN and the resulting 
aqueous solution was extracted with EtOAc (3 × 20 ml). The combined extracts were washed 
with brine (20 ml), dried over Na2SO4, filtered and concentrated to yield scytonemin (4 mg, 
24%) as a green/brown solid; Spectroscopic data agreed with our previous reports. 
 
